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The focus of this thesis is on the differences between Roma and non-
Roma patients regarding their mortality in the period after coronary 
angiography (CAG) and the degree to which medical risk factors and 
other factors contribute to these differences. Additionally, this thesis deals 
with revealing possible pathways among Roma ethnicity, socioeconomic 
status (SES), self-rated health (SRH) and coronary artery disease (CAD). 
This introductory chapter defines CAD and describes its epidemiology, 
lethality and the medical risk factors and other factors that contribute to 
it. Next, we will go into Roma ethnicity and differences between Roma 
and non-Roma in relation to risks for CAD. Research questions are then 
formulated and linked to the thinking model that lies behind this thesis. 
The chapter ends with an outline of the thesis.
1.1  Coronary artery disease, definition and epidemiology
Coronary artery disease (CAD), also known as coronary heart disease 
(CHD) or ischemic heart disease, is a condition which encompasses 
several groups of patients: those having acute coronary syndromes 
caused usually by acute coronary thrombosis, and those with stable 
forms of CAD presenting as stable angina pectoris or dyspnea (1). Stable 
CAD is most commonly caused by obstruction of the coronary arteries by 
atheromatous plaque growing in the time based on atherosclerotic process 
(2). It is generally characterized by episodes of reversible myocardial 
ischemia presenting as transient chest discomfort, which are usually 
inducible by exercise or emotional stress. Stable CAD also includes 
stabilized, asymptomatic forms of CAD that follow an acute coronary 
syndrome. This thesis deals only with stable CAD described hereinafter 
as simply CAD.
The diagnosis of CAD is based on clinical symptoms, among which 
angina pectoris is the most important. It usually presents with typical 
retrosternal chest pain. The prevalence of angina in population-based 
studies increases with age in both sexes, from 5-7% in women aged 45-64 
years to 10-12% in women aged 65-84 years and from 4-7% in men aged 
45-64 years to 12-14% in men aged 65-84 years (3). The annual incidence of 
uncomplicated angina pectoris is 1.0% in male Western populations aged 
45–65 years, with incidence in women under the age of 65 being slightly 
higher. After age 65, the incidence in men and women increases steeply 
with age, towards almost 4% at age 75–84 years (4). Ischaemic heart 
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disease was the leading cause of disability-adjusted life years (DALYs) 
worldwide in 2010, up from being ranked fourth in 1990 and increasing 
by 29% (5). Within the coming decades the DALYs estimate is expected to 
rise from a loss of 85 million DALYs in 1990 to a loss of approximately 150 
million DALYs globally in 2020, thereby remaining the leading somatic 
cause of loss of productivity (6).
In 2013, CAD was the most common cause of death worldwide, 
resulting in 8.14 million deaths (16.8%) (7). Regional differences, as well as 
differences between low- and middle-income countries and high-income 
countries cause variations in the outcomes between populations around 
the world. Cardiovascular disease mortality in Europe has changed over 
the past decades: age-standardized death rates have declined, especially in 
Western European countries, but mortality due to cardiovascular diseases 
in Eastern Europe has remained high (8). Thus, CAD still remains the major 
cause of premature death in Europe, and it affects both men and women.
The differing recent trends in mortality have therefore led to 
increasing geographic inequalities in the burden of CAD between 
European countries; e.g. for some Eastern European countries, including 
Russia and Ukraine, the mortality rate due to CAD for 55–60 year olds 
is higher than the rate in France for people aged 20 years older (9). For 
Slovakia, CAD age-standardized mortality rates for men were 333.8 
and for women 209.5 per one hundred thousand in the year 2010, with 
a 10-year change of -9% and -11% respectively (9). This places Slovakia 
somewhere in the middle of the rates in the former Soviet Block. 
Among the most important clinical predictors of patient outcomes 
in CAD are the ejection fraction of the left ventricle (EF) and the New 
York Heart Association (NYHA) functional class. A lower EF, measured 
either by ultrasound or assessed by ventriculography during invasive 
coronary angiography, cardiac computed tomography or magnetic 
resonance examination, is associated with poorer patient survival (10). 
The NYHA functional classification was used mostly for selection in heart 
failure trials, but is useful as a simple method for measuring a change of 
symptoms over the time. A higher NYHA class is associated with a worse 
prognosis for the CAD patient (10). These two parameters can be used for 
measuring changes in the clinical status of CAD patients.
1.2  Risk factors and therapy of coronary artery disease
CAD is a chronic and multifactorial disease strongly connected to 
lifestyle. The World Health Organization stated that over three-quarters 
of all cardiovascular disease mortality may be prevented with adequate 
changes in lifestyle (8). The efforts of international cardiological societies, 
health policy makers, health care systems and other involved communities 
are attempting to decrease the burden of this disease by influencing the 
main risk factors of CAD. 
The classical Framingham risk factors – age, sex, cigarette smoking, 
blood pressure, total cholesterol and high density lipoprotein (HDL) 
cholesterol – have proved to be consistent risk factors in every population 
studied (2). Obesity and physical inactivity remain important contributors 
(2). Diabetes mellitus is also associated with increased cardiovascular 
morbidity and mortality, but it is considered to be a separate disease, 
which plays a role on the causal path to CAD but is not the ultimate cause. 
Certain types of dyslipidaemia, such as elevated total cholesterol, LDL 
cholesterol and triglycerides and a decreased level of HDL cholesterol, are 
also risk factors. These laboratory outcomes indicate a worse prognosis for 
patients. Other risk indicators for CAD are age, gender and psychosocial 
risk factors like low socioeconomic status, lack of social support, stress 
at work and in family life, depression, anxiety, hostility and type D 
personality (8).
Prevention strategies target the modifiable risk factors of CAD via 
their identification and assessment of a risk score (8). Primary prevention 
includes specific practices for the prevention of the disease among the 
entire population, including those without overt CAD. Secondary 
prevention relies on screening, early detection and diagnosis of CAD 
in order to prevent further progression of the disease. In the cardiology 
literature, the term ‘secondary prevention’ has been used both as an 
equivalent of screening and as denoting risk-factor reduction in people 
who are already under treatment for cardiac diseases.
Therapeutic interventions comprise lifestyle changes, such as 
cessation of smoking, weight reduction, dietary changes, specific drug 
therapy to control the main risk factors and interventional or surgical 
procedures to secure myocardial revascularization. In stable CAD, 
aspirin, statins, beta-blockers and angiotensin converting enzyme 
inhibitors or angiotensin II receptor antagonists are the recommended 
treatment according to currently valid guidelines (3). Invasive coronary 
angiography (CAG) is considered to be the gold standard in revealing the 
atherosclerosis of the coronary arteries, enabling subsequent percutaneous 
coronary intervention (PCI) with or without stent implantation. Based on 
the clinical status of the patient and coronary anatomy, coronary artery 
bypass grafting (CABG) might be the method of choice for myocardial 
revascularization (3).
1.3  Self-rated health as an early marker of prognosis in coronary 
artery disease
Self-rated health (SRH) has gained attention over the past decades and at 
present is recognized as a clinically relevant construct useful for assessing 
the impact of CAD on a patient, the effectiveness of interventions and 
the risk of future CAD (11). SRH as a simple measure of general health 
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attempts to measure health in all of its dimensions. It answers the question 
“In general, would you say that your health is excellent, very good, good, 
fair, or poor?”  In CAD, SRH has been shown to be a strong predictor 
of mortality (12-14). Poorer SRH scores were significant predictors of 
increased mortality and thus of worse prognosis for patients.
1.4  Roma ethnicity and coronary artery disease
Roma constitute the biggest minority in Central and Eastern Europe (15), 
and the European Union estimates that 5 to 10 million Roma currently 
live in the EU (16). In Slovakia, Roma make up the second largest ethnic 
minority, the largest being Hungarian. Estimates of the share of the 
Roma in the Slovak population vary from 2.0% according to the last 
Population and house census in the Slovak Republic in 2011 (17) to 7.2% 
(approximately 380,000 Roma) according to the Institute of Informatics 
and Statistics of the Slovak Republic (18).
Over recent years there has been an increasing recognition of 
ethnic inequalities, with the Roma population having a disadvantaged 
position (19-30). Previous studies found an increased mortality and worse 
health status in Roma. Only a part of this unfavourable health outcome 
can be explained by their lower socioeconomic status, however (24,25). 
Psychosocial factors, such as health-related quality of life, anxiety, sense 
of coherence and hostility, also contribute to this unfavourable outcome 
among Roma (31,32). Nevertheless, data on Roma ethnicity and CAD 
are still very scarce and inconsistent, and we lack sound data on their 
prognosis in CAD and on the explanation of differences between Roma 
and non-Roma regarding this prognosis.
1.5  Primary aim of the study and research questions
The primary aim of this study was to explore the association between 
Roma ethnicity and CAD and its prognosis in patients undergoing CAG. 
Scarce data are available on the specific Roma ethnicity with regard to 
CAD and their outcomes. As the first step, this study will focus on the 
relationship of the Roma ethnicity, medical risk factors and the severity 
of the CAD. This study will include changes in clinical status and SRH 
over the follow-up period. In the next step, mortality rates of the Roma 
patients after CAG will be explored. To our knowledge, no data regarding 
mortality in Roma patients after CAG have yet been published. This study 
also aims to provide an explanation of ethnic differences in all-cause 
mortality in patients after CAG and to look for effects of Roma ethnicity 
on mortality and SRH.
The basic model of the study is summarized in Figure 1.1. The five 
research questions listed below are embedded in this model. 
Figure 1.1 Model of the relationships examined in the thesis, regarding CAG referred patients
CAD – Coronary artery disease; CAG – coronary angiography; RQ – research question
Research question 1:
Do Roma coronary heart disease patients have more medical risk factors 
and greater severity of coronary heart disease than non-Roma?
Research question 2:
What is the seven years’ mortality in Roma and non-Roma patients after 
coronary angiography?
Research question 3:
What makes the difference in the eight years’ mortality of Roma and non-
Roma patients after coronary angiography?
Research question 4:
Does poorer self-rated health mediate the effect of Roma ethnicity 
on mortality in patients with coronary artery disease after coronary 
angiography?
Research question 5:
What are the changes in clinical status, health behavior and self-rated 
health after coronary angiography in Roma and non-Roma Coronary 
Artery Disease patients?
1.6  The structure of the thesis
This thesis is divided into eight chapters.
Chapter 1 ‘Introduction’ provides a general introduction, with a 
theoretical background on CAD, its risk factors, outcomes, SRH and 
Roma ethnicity. It describes the conceptual framework of the thesis and 
the research questions.
Chapter 2 ‘Data sources, measures and statistical analyses’ provides 
information on the design of the study, data collection and the study 
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sample. Furthermore, it describes the measures and statistical analyses 
used in Chapters 3-7.
Chapter 3 ‘Roma coronary heart disease patients have more medical risk 
factors and greater severity of coronary heart disease than non-Roma’ explores 
the relationship of the Roma ethnicity, the medical risk factors of CAD 
and the severity of CAD in a sample of patients undergoing routine CAG 
when controlled for age, gender and educational level. The aim of this 
chapter was to determine whether or not the risk profile of Roma patients 
is worse when compared with majority non-Roma patients.
Chapter 4 ‘Seven years’ mortality in Roma and non-Roma patients after 
coronary angiography’ determines what the all-cause mortality is in Roma 
and non-Roma patients with diagnosed CAD during the up to seven years 
follow-up period after CAG when controlled for sociodemographic variables.
Chapter 5 ‘Eight years’ mortality of Roma and non-Roma patients after 
coronary angiography: what makes the difference?’ explores the causes of the 
differences in mortality in Roma patients with CAD when compared with 
non-Roma up to eight years after CAG. 
Chapter 6 ‘Does poorer self-rated health mediate the effect of Roma ethnicity 
on mortality in patients with coronary artery disease after coronary angiography?’ 
focuses on the association between Roma ethnicity and all-cause mortality 
in CAD patients and the role of SRH on this association. A possible 
mediation or moderation effect of the SRH on the association of Roma 
ethnicity with mortality was analyzed. 
Chapter 7 ‘Changes in clinical status, health behaviour and self-rated health 
after coronary angiography in Roma and non-Roma Coronary Artery Disease 
patients’ focuses on changes in the medical risk factors, physical status, 
use of drugs and SRH in Roma and non-Roma patients after CAG.
Chapter 8 ‘Discussion’ presents the main findings of this study, 
discusses them with an emphasis on a comparison with published data, 
argues their strengths and limitations, and suggests implications for 
practice and future research.
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 measures and statistical analyses
This study was based on data collected within the project ‘Social class 
and its impact on patientsʼ functional status and recovery process - 
2009’ (No. 275/2009-LF) and its precursor, the project ‘Social class and 
its impact on a patientsʼ functional status and recovery process after 
cardiological or cardiosurgical intervention’. Both projects were carried 
out as interdisciplinary studies and were based on cooperation between 
the University of Groningen in the Netherlands, the Pavol Jozef Safarik 
University in Kosice and the East Slovakian Institute of Cardiac and 
Vascular diseases in Kosice, Slovakia. The aim of these projects was to 
explore the impact of socioeconomic status and Roma ethnicity on 
health differences among patients undergoing coronary angiography 
(CAG) and cardiological intervention or cardiac surgery in East Slovakia. 
The psychosocial aspects and health-related quality of life in coronary 
artery disease (CAD) patients were studied previously by Skodova (1) 
and Silarova (2). This chapter provides a general overview of the study 
population, data collection, measures and statistical analyses.
2.1  Study population and data collection
These projects were conducted in the East Slovakian Institute for Cardiac 
and Vascular Diseases in Kosice, Slovakia, from November 2004 until 
June 2013. This institute is one of the three tertiary centers in Slovakia 
specialized for the diagnostics and treatment of cardiac and vascular 
diseases, serving primarily the region of East Slovakia, with approximately 
1.5 million inhabitants. Patients were referred here by their cardiologist or 
physician for CAG in cases of suspected or diagnosed CAD for diagnosis 
and further treatment according to valid European Society of Cardiology 
guidelines.
Inclusion and exclusion criteria for baseline examination were 
defined as follows:
Inclusion criteria:
- CAD in the medical history of the patient;
- Age 75 years or less;
- Signed informed consent.
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Exclusion criteria:
- Cardiac diseases other than chronic forms of CAD (e.g. acute coronary 
syndromes, including acute myocardial infarction, severe valve disease, 
severe atrial or ventricular septal defects, pericarditis or myocarditis, 
cardiomyopathies other than ischaemic, pulmonary embolism);
- Severe cognitive impairments (e.g. dementia, mental retardation) or 
psychiatric disorders in the medical history (e.g. depression, bipolar 
disorder, schizophrenia);
- Severe comorbidity (e.g. malign tumors, dialysed patients, nervous 
system diseases).
Data collection consisted of two measurements: a baseline measurement 
T0 (the day preceding the CAG) and a follow-up examination T1 (12-26 
months later). During the baseline measurement, extraction of data from 
medical records and a physical examination, including blood pressure 
and heart rate measurements, were performed by a cardiologist. A 
psychologist or trained research assistant conducted an interview with 
each participant. Patients were invited for a follow-up examination via 
postal mail. During the follow-up the same type of interview as at the 
time of enrollment was conducted, as well as a physical examination of 
the patient, with extraction of data from medical records performed by a 
cardiologist. 
Between November 2004 and June 2013 approximately 20,000 
patients scheduled to undergo CAG satisfied the inclusion criteria for 
this project, and 1010 consecutive patients were asked to participate in 
the study. We stratified them by SES, measured by educational level and 
then sampled per stratum to obtain equal numbers of these categories per 
stratum. A total of 41 (4.2%) refused to participate (response rate 95.9%) 
and 92 (9.1%) were excluded based on the exclusion criteria. 
Out of those included, 254 (25.1%) patients had a normal CAG, 20 
(7.9%) of whom were Roma. Thus, the population at baseline consisted of 
623 patients, 103 of whom were Roma. As the five articles (Chapter 3 – 7) 
used in this thesis were written at different times during data collection, 
different populations are used in these chapters. The numbers concerned 
are shown in Table 2.1. In the first two articles another 82 Roma patients, 
whose data were collected in the years 2001-2003, before these projects 
started, were included.
The study was approved by the Ethics Committee of the East 
Slovakian Institute for Cardiac and Vascular Diseases in November 2004. 
All participants were provided with information about the study and 
voluntarily signed an informed consent statement prior to the study. The 
study was performed according to the Declaration of Helsinki.
Table 2.1 Description of the study population as used in the chapters
Study 
population Chapter 3 Chapter 4 Chapter 5 Chapter 6 Chapter 7
Study design cross-sectional longitudinal longitudinal longitudinal longitudinal



















Follow-up Up to 7 years Up to 8 years Up to 9 years 12-26 months
Time period 2001-2010 2001-2011 2004-2012 2004-2013 2004-2013
Roma (n, %) 132 (19.6%) 167 (20.5%) 110 (13.2%) 103 (16.5%) 25 (9.5%)
2.2  Measures
We obtained data on sociodemographic background, clinical status, self-
rated health (SRH) and all-cause mortality during the interview with the 
patient, physical examination or from medical records. 
Sociodemographic data included age, gender and educational level. 
Educational level was classified into three categories – low (elementary 
school or secondary school without school leaving exam), middle 
(secondary school with school leaving exam) and high (university 
degree). Ethnicity was measured based on each patient’s declaration and 
identification by the doctor. In case of conflicting opinions, an independent 
third person (a head nurse) was decisive. 
Clinical data were retrieved from the medical records. These included 
disease history, use of drugs and type of treatment after CAG. Disease 
history concerned previous myocardial infarction, arterial hypertension, 
diabetes mellitus and dyslipidaemia. The functional status of the patient 
was assessed using the Canadian Cardiovascular Society (CCS) and New 
York Heart Association (NYHA) functional classifications (Tables 2.2 and 
2.3). The CCS identifies the severity of chest pain in 4 classes (3), and the 
NYHA classifies dyspnea symptoms in 4 classes (4,5). In both scales, a 
higher score represents worse symptomatology. Regarding the use of drugs, 
we collected data about the most commonly used cardiovascular drugs, 
like acetylsalicylic acid (ASA), clopidogrel, beta-blockers, angiotensin 
converting enzyme inhibitors, statins, nitrates, anxiolytics and non-steroid 
anti-inflammatory drugs (NSAIDs). We also asked about smoking status 
(smoker or non-smoker) and alcohol use (alcohol consumption yes or no). 
Based on a physical examination of each patient, body mass index (BMI), 
systolic and diastolic blood pressure and heart rate were registered. Levels 
of total, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) 
cholesterol and triglycerides were registered according to laboratory 
findings. The ejection fraction was measured by ultrasound using either the 
Simpson method or estimated by the occulometric method. Moreover, we 
obtained data on coronary findings from CAG. 
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Table 2.2 Canadian Cardiovascular Society Functional Classification (3)
Class I Ordinary physical activity does not cause angina, such as walking and climbing 
stairs. Angina with strenuous or rapid or prolonged exertion at work or 
recreation.
Class II Slight limitation of ordinary activity. Walking or climbing stairs rapidly, walking 
uphill, walking or stair climbing after meals, or in cold, or in wind, or under 
emotional stress, or only during the few hours after awakening. Walking more 
than two blocks on the level and climbing more than flight of ordinary stairs at 
a normal pace and in normal conditions.
Class III Marked limitation of ordinary physical activity. Walking one to two blocks on 
the level and climbing one flight of stairs in normal conditions and at normal 
pace.
Class IV Inability to carry on any physical activity without discomfort – angina syndrome 
may be present at rest.
Table 2.3 New York Heart Association functional classification based on severity of symptoms and 
physical activity (4) 
Class I No limitation of physical activity. Ordinary physical activity does not cause 
undue breathlessness, fatigue, or palpitations.
Class II Slight limitation of physical activity. Comfortable at rest, but ordinary physical 
activity results in undue breathlessness, fatigue, or palpitations.
Class III Marked limitation of physical activity. Comfortable at rest, but less than 
ordinary physical activity results in undue breathlessness, fatigue, or 
palpitations.
Class IV Unable to carry on any physical activity without discomfort. Symptoms at rest 
can be present. If any physical activity is undertaken, discomfort is increased.
The type of treatment following the CAG concerned conservative 
pharmacological treatment, percutaneous coronary intervention (PCI) 
or coronary artery bypass grafting (CABG). This was decided on by 
cardiologists based on the results of CAG and the patient’s clinical status, 
independently of participation in this study. The severity of the CAD was 
evaluated using the CCS and NYHA functional classifications and by the 
number of diseased coronary vessels found in the CAG, e.g. one-vessel, 
two-vessel or three-vessel disease.
Self-rated health (SRH) was measured using the first question of the 
Short Form Health Survey (SF-36) (6). The validity and reliability of the SF-
36 scale have been established in patients with coronary artery disease (7). 
Data on patient mortality after CAG were obtained from the Central 
Registry of the Health Care Surveillance Authority of the Slovak Republic. 
This authority registers on its web based portal the status of the health 
insurance of each citizen of the Slovak Republic. After identification of the 
patient according to his or her specific birth number, it gives answers the 
question of whether a person is currently insured or not. If not, it gives a 
more specific answer – either the health insurance is currently not valid or 
the patient died. In that case the date of death is given.
2.3  Statistical analyses
Statistical analyses were performed using the statistical software program 
PASW SPSS version 16.0.1, 18.0 and 20.0 for Windows (SPSS Inc., Chicago, 
Illinois, USA) and the statistical program Mplus 7.1 (Muthen&Muthen, 
Los Angeles, USA). First, the sociodemographic and clinical characteristics 
of the studied populations were described. Differences were statistically 
tested using the t-test or Mann-Whitney U-test for continuous variables 
and χ2 or Fisher exact tests, when appropriate, for categorical variables. 
Values of p<0.05 were considered to be statistically significant. Changes 
over time were tested using paired t-tests or related-samples Wilcoxon 
signed rank tests for continuous variables and χ2 square tests or McNemar 
tests for categorical variables, as appropriate (Chapter 4). Then linear 
and logistic regression analyses, with adjustments for age, gender and 
education, were performed in order to assess the effect of ethnicity on 
the outcome variables (Chapters 3, 4). Kaplan-Meier curves of mortality 
were plotted, and log-rank tests between Roma and non-Roma patients 
were computed in Chapters 5 and 6. Hierarchical Cox regression models 
explored the effect of ethnicity and SRH on mortality (Chapters 5, 6, 7). 
Possible mediation between ethnicity and self-rated health was tested 
according to Baron and Kenny (Chapter 7) (8).
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Abstract 
Objectives: Coronary heart disease (CHD) is the most common cause 
of mortality and morbidity world-wide. Evidence on ethnic differences 
between the Roma and non-Roma regarding medical risk factors is scarce. 
The aim of this study was to assess differences in medical risk factors and 
the severity of CHD in Roma compared with non-Roma CHD patients, 
adjusted for gender, age and education.
Methods: 674 patients were included in this cross-sectional study (132 
Roma, 542 non-Roma). Data on medical risk factors, symptoms, medication 
and severity of CHD were obtained from medical records. After matching 
Roma and non-Roma according to education, linear and logistic regression 
analyses with adjustments for gender and age were used.
Results: Compared with non-Roma, Roma patients had significantly 
more risk factors and more severe types of CHD. They were treated 
less frequently with statins and beta-blockers, were more frequently left 
on pharmacotherapy and surgically revascularised. These differences 
remained after controlling for education, gender and age.
Conclusion: Roma CHD patients have a worse risk profile at entry of care 
and seem to be undertreated compared with non-Roma CHD patients.
Keywords
Roma; coronary heart disease; medical risk factors; coronary angiography
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Introduction
Coronary heart disease (CHD) ranks among cardiovascular diseases as 
the most common cause of mortality and morbidity. The publication 
“European Cardiovascular Disease Statistics 2008” (1) showed that CHD 
remains the most common cause of death in the European Union. The 
Framingham Heart Study was one of the first studies to show that medical 
risk factors – e.g. age, total and high-density lipoprotein cholesterol, 
systolic blood pressure, treatment for hypertension, smoking and 
diabetes status – influenced the prevalence and incidence of CHD in the 
general population (2). Today many health organisations, institutions and 
governments are trying to target the population as a whole and people 
at high risk in particular, in order to reduce the burden of increasing 
numbers of cardiovascular deaths and morbidity (3). 
Ethnic minorities seem to generally have unfavorable medical risk factors 
more frequently than majority populations (4,5), but studies on ethnic 
differences regarding this trend are relatively scarce. Capuccio et al. 
found higher prevalence rates of cardiovascular risk factors in certain 
ethnic groups in Britain compared with the majority population (5-7). 
The associaton between socioeconomic status (SES) and cardiovascular 
disease risk factors has also been described in the past (8-10).
One of the largest minority groups in Central and Eastern Europe is the 
Roma population. The highest concentration of Roma in Europe can be 
found in the Balkan and the Carpathian regions. In the Slovak Republic 
Roma are considered to be the second largest minority group (11). 
According to professional demographic estimates, approximately 380,000 
Roma live in Slovakia, which represents 7.2% of the total population of 
the country (12). Previous studies have found higher mortality and lower 
life expectancy for Roma than for non-Roma (13,14). Ginter et al. reported 
that premature/untimely cardiovascular mortality occurred more than 
2.5 times more frequently among male Roma than among the average 
male in the Slovak population (11). High prevalence rates of diabetes, 
chronic infections and obesity, and very high atherogenic indices (total/
HDL cholesterol) were found in this ethnic minority group (11). Kolvek 
showed a higher risk of end stage renal disease to be associated with Roma 
ethnicity, which might be partially explained by a higher occurence of 
diabetic nephropathy (15). Rosicova found Roma ethnicity as a predictor 
of regional infant mortality rate in Slovakia (16). This is likely to contribute 
to the poorer CHD outcomes among Roma (17-19), but evidence on this 
is lacking.
Therefore, the aim of this study was to assess differences in medical risk 
factors for CHD and  the severity of CHD in Roma compared with non-
Roma CHD patients, adjusted for gender, age and education level.
Methods
Patients
Consecutive adult Roma and non-Roma patients undergoing routine 
coronary angiography (CAG) in the East Slovakian Institute for Cardiac 
and Vascular Diseases, Kosice, Slovakia, in the years 2001 - 2010 were 
asked to participate in the study. Ethnicity was measured based on each 
patient’s declaration and identification by the doctor. In the case of a 
mismatch the opinion of a third person (a head-nurse) was decisive. The 
study was approved by the local Ethics Committee, including written 
informed consent.
Procedures and measures 
Socio-demographic data, disease history, health-related behaviour, 
clinical and laboratory examination results, use of drugs, coronary 
findings and type of treatment were collected following the protocol and 
registered in the medical records of each patient. Socio-demographic data 
concerned age and gender. Disease history included family and personal 
history of CHD, previous myocardial infarction, diabetes mellitus, arterial 
hypertension and dyslipidaemia. We also asked about smoking status 
(smoker or non-smoker) and alcohol use (alcohol consumption yes or no). 
Body mass index (BMI), functional status according to the New York 
Heart Association (NYHA - ranging from class I denoting mild dyspnoe 
to class IV denoting severe dyspnoe) and the Canadian Cardiovascular 
Society (CCS - ranging from class I, denoting mild angina, to class IV, 
denoting severe angina) classes, systolic and diastolic blood pressure 
levels, heart frequency and ejection fraction from standard transthoracic 
echocardiography were measured during the clinical examination. Levels 
of total, LDL and HDL cholesterol, triglycerides and serum creatinine 
were registered according to laboratory findings.
Regarding the use of drugs, we collected data about the use of beta-
blockers, nitrates, statins and other common cardiovascular drugs 
(like aspirin, clopidogrel, angiotensin-converting enzyme inhibitors, 
angiotensin-1 blockers or calcium channel antagonists).
Moreover, we obtained data on coronary findings from CAG and 
on treatment modality (conservative pharmacological treatment, 
percutaneous coronary intervention (PCI) or coronary artery bypass 
grafting (CABG)). The type of therapeutic intervention following the CAG 
was determined by cardiologists based on the results of CAG and clinical 
status, independently of participation in this study.
The severity of the CHD was evaluated using the CCS and NYHA 




As the first step, we assessed background and clinical characteristics of the 
Roma and non-Roma patients. Differences were statistically tested using 
the t-test for continuous variables and the χ2-test or Fisher exact test when 
appropriate for categorical variables. Values of p<0.05 were considered 
statistically significant. In the next step, we matched all Roma patients 
with all non-Roma patients according to their education to eliminate 
the influence of the generally low socio-economic status (SES) of Roma 
patients. Then logistic and linear regression analyses, with adjustment 
for gender and age, were performed to assess the effect of ethnicity on 
the above mentioned health-related behaviour, clinical and laboratory 
findings, use of drugs, disease severity and type of treatment. We used 
two models to explain ethnic differences in CHD patients. After matching 
for education to control for socio-economic status, we tested in Model 1 
the crude effect of ethnicity on the outcome variables, and in Model 2 we 
tested the effect of ethnicity adjusted for gender and age. All statistical 
analyses were performed using SPSS 16.0.1.
Results
Baseline characteristics of the study population are presented in Table 
3.1 (N=674). There were 132 Roma and 542 non-Roma patients. Roma 
patients were significantly younger, less frequently women and had more 
frequently a negative family and personal history of CHD, and a positive 
history of myocardial infarction than non-Roma patients. The occurrence 
of arterial hypertension was higher in the non-Roma group. Roma CHD 
patients smoked more frequently, but drank alcohol less frequently 
than the non-Roma patients.  Lower values of systolic blood pressure, 
higher heart frequency, lower levels of HDL cholesterol, higher levels of 
triglycerides and serum creatinine were measured in the group of Roma 
patients when compared with the non-Roma group. In terms of the use 
of drugs, Roma patients used fewer statins and more nitrates (Table 3.1). 
Roma patients showed more severe forms of angina pectoris in the CCS 
classes: there were significantly more of them in the CCS IV class, and they 
had fewer normal CAGs when compared with non-Roma. Furthermore, 
significantly more Roma patients received only pharmacotherapy and 
underwent surgical revascularisation of the myocardium, and they 
underwent PCI with or without stenting less frequently when compared 
with non-Roma patients (Table 3.1).
Table 3.1 Baseline characteristics of the study population by ethnicity (N = 674).Kosice, Slovakia, 2010
* p<0.05, ** p<0.01, *** p<0.001, ns – not significant, bpm – beats per minute; CHD – Coronary Heart 
Disease; CCS – Canadian Cardiovascular Society; CAG – coronary angiography; PCI – percutaneous 
coronary intervention; CABG – coronary artery bypass grafting
Roma (N=132) Non-Roma (N=542)
Significance of 
difference (crude)
Significance of difference 
adjusted for age and gender
Socio-demographic data:
Age (years) 51.9 ± 7.2 57.1 ± 7.4 * ***
Age range (years) 28-71 24-79
Age category distribution
Up to 45 14.4% 6%
46-60 73.5% 60%
Above 60 12.1% 34%
Gender (male/female) 73.5%/26.5% 63.3%/36.7% * ns
Education
Low education 96% 57.2% *** ***
Middle education 2% 19.7% *** **
High education 2% 23.1% *** **
History of the disease:
Negative family history of CHD 32.8% 17.6% * ***
Negative personal history of CHD 44.3% 0.8% * ***
Previous myocardial infarction 60.3% 43.9% * **
Diabetes mellitus 28.2% 30.5% ns ns
Arterial hypertension 61.8% 79.9% * **
Dyslipidaemia 59.5% 51.5% ns ns
Health-related behaviour:
Alcohol consumption 46.4% 66.7% *** ***
Smoking 35.4% 9.8% * ***
Clinical and laboratory findings:
Functional status CCS IV 9.4% 2.2% * **
 Body mass index (kg/m2) 28.9 ± 5 29.0± 4.4 ns ns
Systolic blood pressure (mmHg) 130 ± 22 135 ± 19  * ns
Heart frequency (bpm) 73±10.4 70±10.5 * *
Total cholesterol (mmol/l) 5.29 ±1.06 5.03 ± 1.2 ns ns
HDL cholesterol (mmol/l) 1.13 ± 0.3 1.32 ± 0.67 * ns
LDL cholesterol (mmol/l) 2.95 ± 0.83 3.02 ±1.98 ns ns
Triglycerides (mmol/l) 2.48 ± 1.28 2 ± 1.62 * **
Serum creatinine (mmol/l) 96.7±26.2 90.2±19.4 * *
Ejection fraction (%) 49.7 ± 10 51 ±20 ns ns
Use of drugs:
Statins 45.3% 69.1% * ***
Nitrates 83.8% 65.6% * ***
Beta-blockers 75.2% 82.8% ns ns
Coronary findings:
One-vessel disease 27.9% 23.7% ns ns
Two-vessel disease 27.9% 26.3% ns ns
Three-vessel disease 33.3% 27.6% ns *
Left main disease 3.0% 5.4% ns ns
Normal CAG 9.2% 25.3% *** ***
Type of treatment:
Pharmacotherapy 33.8% 22.4% * *
PCI/stent 18.5% 28.3% * *
CABG 38.5% 24% * ***
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After matching by education level (N=462), we tested in Model 1 the 
crude effect of ethnicity on the above mentioned outcome variables (Table 
3.2). Significantly more Roma patients had a negative family and personal 
history of CHD and a history of previous myocardial infarction. With 
regard to health-related behaviour, Roma patients were more frequently 
smokers. The functional status of Roma patients showed symptoms of 
CCS class IV more frequently. They had higher levels of triglycerides and 
serum creatinine. In the drug treatment, Roma patients used fewer statins 
and beta-blockers, but more nitrates when compared with the non-Roma 
group of patients. Roma patients also had a higher risk of being left on 
pharmacotherapy and not undergoing PCI with or without stenting and 
of being surgically revascularised (Table 3.2).
Model 2 shows that the introduction of age and gender into the model as 
the other most common confounders did not affect most ethnic differences 
in a clinically relevant way, except for the history of dyslipidaemia, alcohol 
consumption, systolic blood pressure and levels of HDL cholesterol, where 
the significant differences among Roma and non-Roma disappeared. The 
risk of having had a previous myocardial infarction and having a higher 
heart frequency measured during physical examination also remained 
higher in the Roma group of patients, but was more strongly associated 
with male gender. Three-vessel disease was associated with Roma 
ethnicity but not as strongly as with male gender and age. Normal CAG 
was associated not only with non-Roma ethnicity, but also with female 
gender and younger age. Roma patients had an even higher risk of being 
treated by CABG after controlling for gender and age.
Adjustment for the period of assessment (2001-2005 vs. 2006-2010) hardly 
changed the size and statistical significance of differences between Roma 
and non-Roma, except for the proportions of patients undergoing PCI/
stenting and three-vessel disease, which were no longer statistically 
significant. Similarly, an additional adjustment for BMI neither affected 
the size nor the statistical significance of any ethnic difference; the biggest 
difference was 1.4%.
Table 3.2 Associations of ethnicity, adjusted for educational level, with history of the disease, health-
related behaviour, clinical and laboratory findings, use of drugs, coronary findings and type of treatment 
adjusted for gender and age: odds ratios (OR) or beta coefficients (B) with 95% confidence intervals 
(95%CI), significance of the model change (smc) (N=462).
Kosice, Slovakia, 2010
* p<0.05, ** p<0.01, *** p<0.001, ns not statistically significant
CI – confidence interval; smc - significance of the model change; HDL – high-density lipoprotein; LDL – 
low-density lipoprotein; CHD – coronary heart disease; CAG – coronary angiography; PCI – percutaneous 
coronary intervention; CABG – coronary artery bypass grafting
Model 1
Ethnicity adjusted for 
educational level (Roma 
vs. non-Roma)
OR or B with (95%CI)
smc Model 2
Ethnicity adjusted for 
educational level, 
gender and age 
(Roma vs. non-Roma) 
OR or B with (95%CI)
smc
History of the disease:
Negative family history of CHD (OR) 1.85 (1.18, 2.94)** ** 2.04 (1.25, 3.33)** *
Negative personal history of CHD (OR) 83.33 (25.64, 250.00)*** *** 76.92 (22.73, 250.00)*** ***
Previous myocardial infarction (OR) 1.64 (1.09, 2.44)* * 1.56 (1.01, 2.44)* **
Arterial hypertension (OR) 0.41 (0.26, 0.64)*** *** 0.58 (0.36, 0.93)* ***
Dyslipidaemia (OR) 1.52 (1.01, 2.33)* * 1.52 (0.98, 2.33) ns
Health-related behaviour:
Alcohol consumption (OR) 0.67 (0.24, 1.83) ns 0.45 (0.16, 1.29) ***
Smoking (OR) 4.76 (2.78, 7.69)*** *** 3.34 (1.98, 5.78)*** ***
Clinical and laboratory findings:
Functional status CCS IV (OR) 20.00 (2.38, 100.00)** *** 34.96 (3.97, 308.13)** ***
Systolic blood pressure (B) 5.38 (0.96, 9.80)* * 2.38 (-2.20, 6.96) ***
Heart frequency (B) -3.13 (-5.35, -0.91)** ** -3.33 (-5.68, -0.99)** ns
HDL cholesterol (B) 0.23 (0.03, 0.43)* * 0.17 (-0.04, 0.38) *
Triglycerides (B) -0.48 (-0.81, -0.15)** ** -0.42 (-0.76, -0.07)* ns
Serum creatinine (B) -7.83 (-12.53, -3.13)** ** -8.43 (-13.21, -3.64)** ***
Use of drugs:
Statins (OR) 0.36 (0.23, 0.56)*** *** 0.38 (0.24, 0.60)*** ***
Nitrates (OR) 2.44 (1.43, 4.35)** ** 2.86 (1.61, 5.00)*** **
Betablockers (OR) 0.58 (0.34, 0.98)* * 0.55 (0.31, 0.96)* ns
Coronary findings:
Three-vessel disease (OR) 0.65 (0.40, 1.05) ns 0.54 (0.32, 0.91)* **
Normal CAG (OR) 0.28 (0.15, 0.54)*** *** 0.23 (0.11, 0.46)*** ***
Type of treatment:
Pharmacotherapy (OR) 1.67 (1.08, 2.63)* * 1.61 (1.01, 2.56)* ns
PCI / stent (OR) 0.59 (0.35, 0.97)* * 0.57 (0.33, 0.95)* ns
CABG (OR) 2.17 (1.39, 3.33)** ** 2.50 (1.54, 4.00)*** ***
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Discussion
In this cross-sectional study of patients undergoing routine CAG, we 
explored the differences between the medical risk factors for CHD and the 
severity of CHD in the Roma compared with non-Roma patients matched 
for education and controlled for gender and age. Significant differences 
were found in the medical risk profile of CHD by Roma ethnicity. Most 
of these differences remained significant even after controlling for 
education, gender and age. Roma patients were younger, were more 
likely to have a negative family and personal history of CHD, a positive 
personal history of myocardial infarction and were more likely to smoke 
than non-Roma patients. They had lower values of systolic blood pressure, 
higher heart frequency, lower levels of HDL cholesterol and higher levels 
of triglycerides. There was also a significant difference in the use of 
drugs that disadvantaged Roma patients. As far as the severity of CHD 
was concerned, the study showed significant differences in the clinical 
symptoms (more Roma patients in CCS IV class), the number of normal 
CAG (fewer Roma had a normal CAG) and the treatment modalities 
(Roma were more likely to be left on pharmacotherapy or to undergo 
surgical revascularisation). These results support the assumption that 
Roma patients come for a CAG examination with worse health status than 
non-Roma. 
The higher percentage of patients with a negative family and personal 
history among Roma might be explained by the lower level of education in 
this group of patients and thus worse knowledge regarding their own health 
status and that of their relatives (20). It seems that in the Roma group lower 
levels of HDL cholesterol and higher levels of triglycerides also contribute 
to the worse medical risk profile of CHD patients. This is probably caused 
by a higher consumption of animal fat with saturated fatty acids and a lack 
of vegetables and fruits in the diets of Roma patients (21). 
Regarding alcohol consumption, no significant difference was found after 
controlling for the above mentioned confounders. The symptoms of CHD 
measured in the CCS classes are worse in the Roma patients: this is closely 
associated with their more severe forms of CHD.  Roma also have three-
vessel disease more frequently and in contrast normal CAGs much less 
frequently. The relative underuse of PCI with or without stenting might 
be explained again by worse coronary findings and thus more need for 
surgical revascularisation. Despite the fact that Roma patients are more 
likely to be left on pharmacotherapy, they are often not treated adequately. 
We found a significant undertreatment with statins and beta-blockers. The 
higher use of nitrates as purely symptomatic drugs might be explained by 
the more severe symptoms in the Roma group of patients.
Previous findings
Results similar to those of our study appear in a study by Nozdrovicky 
(14), who reported that cardiovascular diseases were the most common 
cause of death among Roma, and that the prevalence of smoking was 
also higher in this group of the population. In contrast, Filadelfiova et 
al. (20) found substantially lower rates of long-term illness in the Roma 
population, which might be explained by a different understanding 
of disease among the Roma and the majority population. They also 
identified cardiovascular diseases as the most common types of long-
term illnesses among Roma. Another study, from the western part of 
Slovakia (22), determined higher prevalences of type 2 diabetes mellitus, 
metabolic syndrome, cardiovascular disease, hypercholesterolemia and 
hypertriglyceridaemia in Roma.  We did not find a significant difference 
in the prevalence of diabetes mellitus, and found that hypertension, as one 
of the most important risk factors for the CHD, occurred even significantly 
less frequent in Roma CHD patients. The Whitehall II prospective cohort 
study (23) showed that South Asians tend to be more likely to undergo 
cardiac procedures and to be on secondary prevention drugs than white 
participants. In our study population, Roma patients underwent CABG 
more frequently, but their medical therapy was not optimal.
Previous studies have suggested that the worse health status of Roma 
population might be associated with their lower SES. In our study we 
tried to eliminate this factor by adjusting for education. We found that 
significant differences that disadvantaged the Roma ethnicity still 
remained. This might be partially explained by genetic factors, but other 
factors such as worse access to the health care services, culture, housing 
conditions, language problems or discrimination could play a certain role 
as well (24-26).
Strengths and weaknesses of the study
We collected data from a rather large number of Roma patients with 
CHD in one major cardiac centre in Slovakia, which is unique in this field 
of interest. The weakness of our study includes its observational cross-
sectional design.
Implications
Strategies adopted by European countries including Slovakia to control 
CHD are directed mostly at majority populations. Our study shows 
that Roma CHD patients have a significantly greater risk of CHD due 
to their worse medical risk profile, show significant undertreatment 
with statins and beta-blockers despite having more severe forms of 
CHD and are more frequently left on pharmacotherapy and surgically 
revascularised when compared with non-Roma CHD patients even 
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after controlling for education, gender and age. Differences in clinical 
symptoms and medical treatment suggest that Roma patients should 
require special attention from all health care professionals. These findings 
call for better prevention strategies, including the use of mass media 
information (27) and improvement of the medical treatment in high risk 
Roma CHD patients. 
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Abstract 
Background: Ethnicity is associated with differences in clinical course 
and outcomes of cardiac disease, often in association with a poorer 
socioeconomic position. The aim of this study was to compare the 
mortality after coronary angiography (CAG) of Roma and non-Roma 
patients matched for education and adjusted for gender and age.
Methods: 816 patients were included in the study (167 Roma, 649 non-
Roma). Data on socio-demographic background, disease history, use 
of drugs, coronary findings and type of treatment were obtained from 
medical records. Mortality was assessed up to seven years after CAG. 
Kaplan-Meier curves of mortality were plotted, and differences between 
the Roma and non-Roma patients were assessed using log-rank tests, 
matched for education and adjusted for gender and age.
Results: Mortality after CAG was significantly higher among Roma 
than non-Roma (log-rank test χ2 = 7.59, p < 0.01), and remained so after 
matching for education and adjustment for gender, age, history of 
previous myocardial infarction and abnormal CAG (hazard ratio: 2.07, 
95% confidence interval: 1.13;3.82).
Conclusion: Mortality after CAG is higher among Roma, and this is not 
due to differences in age, gender or education. These results warrant 
further reconsideration of the management of Roma cardiac patients.
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Cardiovascular diseases are the leading cause of death in developed 
countries (1), thus causing a great need for evidence on contributing 
factors. Ethnicity is one of the factors that were found to be associated 
with different mortality rates (2-4). This association could be partially 
explained by the differences found in the occurrence of risk factors of 
coronary artery disease (5,6), while the below average socioeconomic 
status of many ethnic minorities also contributes (7,8).
Roma ethnicity was associated with higher mortality and higher 
occurrence of cardiovascular diseases risk factors in several studies across 
predominantly Eastern Europe (3,9-13), where the majority of the Roma 
population is concentrated. Estimates on the share of the Roma in the 
Slovak population vary from 2.0% according to the last Population and 
house census in the Slovak Republic in 2011(14) to 7.2% according to Vano 
(15). Previous studies in Slovakia found a higher mortality among Roma 
than non-Roma, a higher prevalence of cardiovascular medical risk factors 
(16-20) and a lower socioeconomic status (SES) (21). Evidence on the 
association of SES with worse health outcomes regarding cardiovascular 
diseases is lacking for Roma. 
Therefore, the aim of this study was to compare mortality after coronary 
angiography (CAG) in Roma and non-Roma patients matched for 
education and adjusted for gender and age.
Methods
Patients
A total of  946 consecutive adult Roma and non-Roma patients who 
underwent routine elective CAG in the East Slovakian Institute for 
Cardiac and Vascular Diseases, Kosice, Slovakia, in the years 2001 - 2011 
were asked to participate in our study. We did not collect response data 
for the first 82 Roma patients. Of the remaining 864 patients, 91 were 
excluded because of the exclusion criteria (mental disorders, infectious 
endocarditis, acute myocardial infarction, severe valve disease). Of the 
eligible patients, 39 (5.1%) refused to participate, yielding 734 participants 
(response 94.9%) plus the first 82, i.e. 816. The study was approved by the 
local Ethics Committee, including written informed consent. Each patient 
provided a signed informed consent form prior to the study. 
Procedures and measures 
We collected data on socio-demographic background, disease history, use 
of drugs, coronary findings and type of treatment. Socio-demographic 
data concerned age, gender and level of education (low - elementary 
school and middle school without school leaving examination, middle 
– with school leaving examination or high education). Ethnicity was 
measured based on each patient’s declaration and identification by the 
doctor. In the case of a mismatch the opinion of a third person (a head-
nurse) was decisive. We did not have a single case when a patient declared 
himself or herself as non-Roma but the doctor thought the opposite.
History of the disease concerned previous myocardial infarction, arterial 
hypertension, diabetes mellitus, dyslipidaemia and the use of drugs – 
betablockers, statins and nitrates. Information on the personal medical 
history and medication was taken from medical records following 
international guidelines (22). Coronary findings were assessed from 
the CAG. The type of therapeutic intervention following the CAG 
(conservative pharmacological treatment, percutaneous coronary 
intervention (PCI) or coronary artery bypass grafting (CABG)) was 
determined by cardiologists based on the results of CAG and clinical 
status, independently of participation in this study. The severity of the 
CHD was evaluated using the CCS and NYHA classifications and by the 
number of diseased coronary vessels found in the CAG. We then collected 
data about patients’ mortality from the Central Registry of the Health 
Care Surveillance Authority of the Slovak Republic from one up to seven 
years after CAG, to maximally utilise the entire cohort.
Statistical analyses
As the first step, we assessed background and clinical characteristics of 
the Roma and non-Roma patients. Differences were statistically tested 
using the t-test for continuous variables and the χ2-test or Fisher exact 
test, when appropriate, for categorical variables. Values of p<0.05 were 
considered statistically significant. Kaplan-Meier curves of mortality 
were then plotted, and log-rank tests between the Roma and non-Roma 
group of patients were computed. We next matched Roma and non-Roma 
for education on the group level (low, middle, high educated) because 
of missing data on education in 78 Roma patients. We had data on 
education for 89 Roma and all non-Roma, so we imputed the distribution 
of known Roma education to the whole Roma group and then matched 
Roma 1:2 with non-Roma to control for SES. We used three models in Cox 
regression analyses: in Model 1 we tested the crude effect of ethnicity; 
in Model 2 we adjusted for gender, age and age-squared. Including both 
age and age-squared as adjustment for this combination of measures of 
age has been shown to provide the best adjustment at the dispense of the 
fewest degrees of freedom (23). In Model 3 we additionally adjusted for 
history of previous MI and abnormal CAG. All statistical analyses were 
performed using SPSS 18.
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Results
Baseline characteristics of the study population are presented in Table 4.1 
(N=816). There were 167 Roma and 649 non-Roma patients. Roma patients 
were significantly younger, less frequently women and more frequently 
had a positive history of myocardial infarction and a negative history of 
arterial hypertension than non-Roma patients. There were significantly 
more current smokers among Roma patients. Roma had angina pectoris 
in CCS class IV more frequently and a higher use of nitrates. Though there 
were no differences in the occurrence of dyslipidaemia, Roma patients 
were treated by statins significantly less often. There were significantly 
fewer normal CAGs among Roma but no differences regarding the type of 
treatment after CAG. We found a significant difference in the mean length 
of follow-up between Roma with known education and matched non-
Roma (32.2±27.5 versus 47.5±26.4 months, respectively). The Cox regression 
analysis controlled for these differences in the length of follow-up.
Table 4.1 Baseline characteristics of the study population by ethnicity (N=816)
* p<0.05, ** p<0.01, *** p<0.001, ns – not significant; NYHA – New York Heart Association; CCS – 
Canadian Cardiovascular Society; CAG – coronary angiography; PCI – percutaneous coronary intervention; 





Roma with known 
education (N=89)
Non-Roma matched 
to all Roma (as in first 
column)  (N=334)
Socio-demographic data:
Age (years) 52.1 ± 8.3 57.8±7.4*** 53.9±6.7 57.9±7.3***
Gender (female/male) 29.3%/70.7% 38.7%/61.3%* 29.2%/70.8% 43.7%/56.3%*
Education *** ns
Low education 96.6% 55.8% 96.6% 96.4%
Middle education 2.2% 21.0% 2.2% 2.4%
High education 1.1% 23.2% 1.1% 1.2%
Mean length of follow-up 
(months)
51.9±32.3 47.9±26.8 32.2±27.5 47.5±26.4***
Smoking status 
(current smoker)
58(35.2%) 59(9.3%)*** 30(33.7%) 37(9.8%)***
History of the disease:
Previous myocardial infarction 99(60.0%) 253(39.7%)*** 55(63.2%) 146(44.0%)**
NYHA III-IV 17(17.7%) 56(20.8%)ns 7(24.1% 40(24.5%)ns
CCS IV 11(9.7%) 9(2.8%)** 2(5.3%) 2(1.1%)ns
Dyslipoproteinaemia 99(59.6%) 348(55.2%)ns 47(53.4%) 175(52.9%)ns
Arterial hypertension 109(65.7%) 519(81.9%)*** 62(70.5%) 273(82.7%)**
Diabetes mellitus 46(27.7%) 198(31.1%)ns 26(29.5%) 111(33.4%)ns
Use of drugs:
Betablockers 97(75.8%) 424(82.8%)ns 39(78.0%) 227(83.8%)ns
Statins 60(46.9%) 355(69.3%)*** 33(66.0%) 190(70.1%)ns
Nitrates 105(82.0%) 328(64.1%)*** 40(80.0%) 178(65.7%)*
Coronary findings:
One-vessel disease 34(28.3%) 117(24.3%)ns 8(17.8%) 63(23.6%)ns
Two-vessel disease 31(25.8%) 125(26.0%)ns 13(28.9%) 74(27.7%)ns
Three-vessel disease 40(33.3%) 123(25.6%)ns 17(37.8%) 59(22.1%)*
Left main disease 3(1.8%) 31(4.8%)ns 3(3.4%) 18(5.4%)ns
Normal CAG 17(10.2%) 185(28.5%)*** 10(11.2%) 93(27.8%)**
Type of treatment:
Pharmacotherapy 36(21.7%) 175(27.0%)ns 24(27.0%) 91(27.2%)ns
PCI/stent 36(21.7%) 175(27.0%)ns 24(27.0%) 91(27.2%)ns
CABG 17(37.0%) 119(25.3%)ns 17(37.0%) 59(23.0%)ns
During the follow-up period of seven years, 79 patients died, 732 
remained alive and 5 could not be reached for follow-up. The crude 
mortality was significantly higher in Roma patients (χ2 = 7.59, p < 0.01). 
In the next step, we matched patients according to their educational level 
to examine whether the higher mortality in Roma could be explained by 
education. The all-cause mortality of the Roma was then still higher when 
compared with the non-Roma group of patients (hazard ratio, HR: 1.93, 
95% confidence interval, CI: 1.09; 3.40). Additional adjustment for gender, 
age and age2 increased the relative differences, HR: 2.34, 95% CI: 1.28; 4.27 
(see Figure 4.1 and Table 4.2). Adjustment for history of previous MI or of 
an abnormal CAG did not influence the estimates of excess mortality in 
the Roma group of patients. Additional Cox regression analysis adjusted 
for age, gender, education, history of previous myocardial infarction (MI) 
and abnormal CAG on only Roma with known education and all non-
Roma yielded similar hazard rates. These reached statistical significance 
in the first two models but not in the third model probably due to the 
smaller number of Roma patients. 
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Figure 4.1 7-year all-cause mortality of Roma and non-Roma patients who underwent coronary 
angiography matched for education and adjusted for gender, age and age2.
Table 4.2  Results of Cox regression analysis of ethnicity and 7-year all-cause mortality adjusted for gender, 
age, age2, a history of previous myocardial infarction (MI) and of abnormal CAG in a sample of Roma and 
non-Roma who underwent CAG matched for the education: hazard ratio (HR), confidence intervals (CI), 
significance of the model change (smc) and coefficient of determination (R²) (N=501).
* p<0.05; ** p<0.01; *** p<0.001; ns – not significant; HR – hazard ratio; CI – confidence interval for HR; 
smc – significance of the model change; R2 ‒ coefficient of determination
Roma ethnicity studies are usually restricted to one or two smaller districts 
in one country with a small sample size, with only a few studies analysing 
socio-economic factors(24). Kohler et al. found a higher mortality in the 
Roma minority in Bulgaria, which was not explained by their lower SES 
(3). Sepkowitz described a shorter life-expectancy in the Roma population 
than in the non-Roma population in Slovakia, Bulgaria and Czech 
Republic (25).
Differences were found in the mortality among other ethnicities as well 
(4). Borrell et al. observed the mortality to be lower among Hispanic 
women than among non-Hispanic white women (2). On the other hand, 
Feder et al. did not find any difference in mortality between south Asian 
and white participants among patients appropriate for revascularisation, 
though south Asians were less likely to receive CABG (26). In our sample 
we did not observe any differences regarding the type of treatment 
following CAG.
A lower educational level explained some of the higher mortality after 
CAG among Roma, but only partially. This contradicts the hypothesis that 
low SES is the only reason for their increased mortality. We might consider 
that other factors play a role in this finding, such as genetic factors, a lower 
compliance of the Roma patients to medication, worse access to health 
HR 95% CI smc R2
Model 1 (χ2 = 5.31 *) 0.01
ethnicity (Roma vs. non-Roma) 1.93 (1.09;3.40) * *
Model 2 (χ2 = 9.50) 0.02
ethnicity (Roma vs. non-Roma) 2.34 (1.28;4.27)** ns
Age 1.06 (0.78;1.44)* ns
age2 1.00 (1.00;1.00) ns
gender (male vs. female) 1.04 (0.58;1.86) ns
Model 3 (χ2 = 12.35) 0.03
ethnicity (Roma vs. non-Roma) 2.07 (1.13;3.82) * ns
Age 1.07 (0.79;1.45) ns
age2 1.00 (1.00;1.00) ns
gender (male vs. female) 0.91 (0.50;1.65) ns
previous MI (yes vs. no) 1.21 (0.70;2.11) ns
abnormal CAG (yes vs. no) 2.60 (0.88;7.69) ns
Seven years’ mortality in Roma and non-Roma patients







The aim of this study was to compare the mortality in Roma patients who 
underwent CAG with non-Roma patients who underwent CAG, matched 
for educational level and adjusted for gender, age, history of previous MI 
and abnormal CAG. The seven years’ all-cause mortality in Roma patients 
was significantly higher and remained so after adjustment for the above 
mentioned potential confounders.
We found higher mortality among Roma, which is in line with the findings 
of Nozdrovicky (18), Ginter (16), Bogdanovic (9) and Kohler (3). These 
studies reported higher mortality in Roma, but without adjusting for age, 
gender or education (18). Ginter et al. found a 2.5-times higher unadjusted 
mortality in Roma males than in non-Roma, as well as a higher prevalence 
of cardiovascular risk factors among Roma than non-Roma in Slovakia 
(16). In Serbia, overall mortality has been shown to be higher in Roma 
than in the majority population, but the cardiovascular morbidity was 
significantly lower (9).
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care services, bad housing conditions, inadequate nutrition, culture, 
language problems with health care professionals or discrimination.
The excess mortality that the Roma have after matching for educational 
level might be explained by differences in their medical factors. We 
found fewer normal CAGs, a more frequently positive history of previous 
myocardial infarction and worse CCS symptoms in Roma patients and thus 
more frequently expected a diagnosed CHD that might lead to increased 
mortality. The 28.5% proportion of normal coronary angiograms in the 
non-Roma group of elective patients is in line with previous reports(27,28). 
The lower use of statins as one of the major drugs used in primary as 
well as secondary prevention of CHD in the Roma patients might also 
contribute to the higher mortality in this group. Vozarova de Courten et 
al. reported a higher incidence of type 2 diabetes mellitus and metabolic 
syndrome (19), but in our study we did not observe any difference between 
the groups of patients regarding diabetes mellitus and dyslipidaemia. On 
the contrary, the lower occurrence of arterial hypertension in the Roma 
group of patients contradicts the hypothesis of their worse health status. 
Strengths and limitations of the study
This prospective, single major cardiac center study presents unique data 
on the long-term mortality of a rather large sample of Roma patients who 
underwent CAG and the influence of  socioeconomic status on it and 
on a comparison group from the majority population living in the same 
region. An additional strength of this study is its relatively high response 
rate. Moreover, loss to follow-up over the years was very low.
One of the limitations is the lack of knowledge of the cause of death in 
patients, making it impossible to distinguish between cardiac and non-
cardiac mortality in the studied population. Among the limitations is the 
missing information on education in a part of the Roma group. We tried to 
solve this problem by imputing the missing data and then performing an 
analysis with matching. There is evidence on the generally low educational 
level of the Roma population in Slovakia, which is in accordance with our 
data (21). Data on the ejection fraction as one of the prognostic factors were 
lacking for a rather large part of the study population (28.7%); therefore, 
we did not present them.
Implications
This study adds more insights into the understanding of the health status 
differences in Roma cardiac patients compared with non-Roma cardiac 
patients. The higher mortality among Roma, which could be partially 
explained by their worse clinical status at the time of CAG,  call for a more 
aggressive approach in the primary as well as secondary prevention and 
treatment of cardiovascular diseases in the Roma population. A higher 
mortality among Roma which cannot be explained only by the lower 
socioeconomic status of this minority calls for further investigation in this 
field. Results must be verified in a larger sample and followed-up for a 
longer period to allow for generalisation. Other factors influencing the 
higher mortality in Roma patients than their health status and SES, such 
as the severity of the coronary heart disease or ejection fraction, have to 
be further investigated. This study was conducted in patients with stable 
CHD, implying that these findings cannot automatically be applied on 
patients with unstable forms of CHD. Future research has to confirm or 
refute whether the same concerns acute coronary syndromes.
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Abstract 
Background: The increased mortality in Roma is assumed to be 
associated with their lower socioeconomic status and higher prevalence of 
cardiovascular disease risk factors. The aim of this study was to compare 
the all-cause mortality after coronary angiography (CAG) in Roma and 
non-Roma patients and to assess whether differences in educational level, 
medical risk factors, severity of the coronary heart disease and type of 
treatment contributed to differences in this mortality.
Methods: 832 patients were included in the study (110 Roma, 722 non-
Roma). Data on sociodemographic background, disease history, use 
of drugs, coronary findings and type of treatment were obtained from 
medical records. Mortality was assessed up to eight years after CAG. 
Kaplan-Meier curves of mortality were plotted, and differences between 
the Roma and non-Roma patients were assessed using log-rank tests, 
adjusted for gender, age, education and medical factors.
Results: Mortality after CAG in Roma was higher after adjustment for 
gender, age and education (hazard ratio: 2.03, 95% confidence interval 
1.04; 3.98). Male gender, lower education and NYHA class III or IV 
explained about one-half of the excess of Roma mortality.
Conclusion: The excess of Roma mortality after CAG can be partially 
explained by their lower education and worse clinical status. Improvement 
of their socioeconomic and clinical status before undergoing CAG may 
lower the increased risk of death in Roma patients.
Keywords




Cardiovascular diseases (CVD) continue to cause the highest share of 
global mortality, including in Europe (1). They remain the major cause 
of premature death in Europe, even though CVD mortality has fallen 
considerably over recent decades in many European countries(2). All-
cause mortality was shown to be increased in Roma, which are the biggest 
minority in central and eastern European countries (3-7). In general, Roma 
live about 10 years shorter than their non-Roma counterparts from the 
same region and have a higher prevalence of coronary artery disease and 
cardiovascular disease risk factors, including smoking, diabetes mellitus, 
dyslipidaemia and obesity (6,8-15). 
The majority of the Roma population in Europe is concentrated in 
the central and eastern parts of the continent, which includes Slovakia. 
Estimates on the share of Roma in the Slovak population vary from 
2.0% according to the last population and housing census in the Slovak 
Republic in 2011(16) to 7.2% (approximately 380,000 Roma) according to the 
Institute of Informatics and Statistics of the Slovak Republic (Infostat) (17). 
Roma in Slovakia have been shown to have a poorer health in a number of 
recent studies (5,8,18-20). Their lower socioeconomic status only partially 
explains their worse health outcomes (15,18-22), though most studies 
were rather descriptive, and only a few covered explanatory factors (4,15). 
Moreover, mortality data that compare Roma and non-Roma ethnicity are 
very scarce, especially regarding cardiovascular disease mortality.
The aim of this study was to compare the all-cause mortality after 
coronary angiography (CAG) in Roma and non-Roma patients crude 
and adjusted for age and gender, and to assess whether differences in 
educational level, medical risk factors, severity of the coronary heart 
disease and type of treatment contributed to these differences in mortality.
Methods
Patients
A total of 964 consecutive adult Roma and non-Roma patients who 
underwent routine CAG at the East Slovakian Institute for Cardiac and 
Vascular Diseases in Kosice, Slovakia, in the years 2004 - 2012 were 
asked to participate in our study. We excluded 94 based on the exclusion 
criteria (i.e., mental disorders, infectious endocarditis, acute myocardial 
infarction, severe valve disease). Of the eligible patients, 38 (4.4%) refused 
to participate, leading to 832 participants (response 95.6%). The study was 
approved by the local Ethics Committee. Each patient provided a signed 
informed consent form prior to the study. 
Procedures and measures 
We collected data on sociodemographic background, disease history, 
use of pharmaceuticals, coronary findings and type of treatment. 
Sociodemographic background comprised age, gender and level of 
education (low - without school leaving examination versus high – 
middle with school leaving examination and university). Ethnicity was 
measured based on each patient’s declaration and identification by the 
doctor. In case of conflicting opinions, an independent third person (a 
head-nurse) was decisive. We computed each patient`s body mass 
index (BMI) according to their measured height and weight. Disease 
history concerned previous myocardial infarction, arterial hypertension, 
diabetes mellitus, dyslipidaemia and the use of acetylsalicylic acid 
(ASA), clopidogrel, betablockers, statins, nitrates and non-steroid anti-
inflammatory drugs. We also asked about smoking status (smoker or non-
smoker) and alcohol use (alcohol consumption yes or no). Levels of total, 
LDL and HDL cholesterol and triglycerides were registered according to 
laboratory findings. 
Coronary findings were assessed by CAG. The type of treatment 
following the CAG concerned conservative pharmacological treatment, 
percutaneous coronary intervention (PCI) or coronary artery bypass 
grafting (CABG). This was decided on by cardiologists based on the results 
of CAG and the patient’s clinical status, independently of participation 
in this study. The severity of the coronary heart disease (CHD) was 
evaluated using the Canadian Cardiovascular Society (CCS) and New 
York Heart Association (NYHA) classifications and by the number of 
diseased coronary vessels found in the CAG. Data on patient mortality 
during the eight years after CAG were obtained from the Central Registry 
of the Health Care Surveillance Authority of the Slovak Republic.
Statistical analyses
As the first step, we assessed background and clinical characteristics of 
the Roma and non-Roma patients. Differences were tested statistically 
using the t-test for continuous variables and χ2 or Fisher exact tests, when 
appropriate, for categorical variables. Values of p<0.05 were considered to 
be statistically significant. 
Next, Kaplan-Meier curves for all-cause mortality were plotted, and 
log-rank tests between the Roma and non-Roma groups of patients were 
computed, crude and adjusted for age, gender and education. Missing 
data for the variables HDL cholesterol (19.8%) and triglycerides (16.1%) 
were complemented by a multiple imputation method in SPSS to increase 
the number of valid cases in the Cox regression analysis. First, patterns 
of missing data were analyzed to explore whether data are missing at 
random or systematically. As no systematic error was detected, in the 
second step, five datasets were imputed using fully conditional linear 
regression imputations. 
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Finally, statistical analyses (specified below) were performed on the 
original datasets as well as on the imputed datasets and pooled estimates 
were calculated. As the last step we used a five-step Cox regression model 
to explain the differences in mortality. Model 1 tested the crude effect 
of ethnicity on all-cause mortality; Model 2 tested the effect of ethnicity 
when controlling for age, age² and gender; Model 3A added education 
dichotomized into two categories to Model 2. Model 3B added medical 
factors to Model 2. Finally, Model 4 contained all variables, i.e. Model 2 
plus educational level and medical factors. All statistical analyses were 
performed using SPSS 20.
Results
Baseline characteristics of the study population are given in Table 5.1. 
Roma patients were significantly younger, smoked more frequently, had 
lower education and a significantly worse medical risk profile at the time 
of CAG. There were significantly fewer normal CAGs in the Roma group 
of patients, but no differences regarding the number of diseased coronary 
vessels and type of treatment, except for pharmacotherapy, were found. 
Roma patients used antiplatelet therapy (ASA and clopidogrel) more 
frequently as well as non-steroid anti-inflammatory drugs (NSAID) when 
compared with non-Roma.
Table 5.1 Baseline characteristics of the study population by ethnicity (N=832)
* p<0.05; ** p<0.01; *** p<0.001; ns – not significant; BMI – body mass index; ASA – acetylsalicylic acid; 
NSAID – non-steroid anti-inflammatory drugs; CAG – coronary angiography; PCI – percutaneous coronary 
intervention; CABG – coronary artery bypass grafting
Roma (N=110) Non-Roma (N=722) Significance of difference
Sociodemographic data:
Age (years) 53.7 ± 6.5 58.3 ± 7.5 *** 
Age range (years) 35-73 24-75
Age category distribution
     Up to 45 9.1% 4.8%
     46-60 76.4% 55.3%
     Above 60 14.5% 39.9%
Gender (male/female) 69.1%/30.9%   59.4%/40.6% ns
Education ***
     Low education 97.3% 56.4%
     Middle education 1.8% 18.7%
     High education 0.9% 24.9%
BMI (kg/m²) 30.17±5.29 29.69±11.21 ns
History of disease:
Previous myocardial infarction 69(62.7%) 289(40.0%) ***
NYHA III-IV 18(20.5%) 110(21.4%) ns
CCS IV 16(15.8%) 43(7.2%) **
Dyslipoproteinaemia 71(64.5%) 434(60.2%) ns
Arterial hypertension 86(78.2%) 609(84.7%) ns
Diabetes mellitus 36(32.7%) 233(32.3%) ns
Smoking 36(33.0%) 66(9.2%) ***
Alcohol 3(2.7%) 26(3.6%) ns
Use of drugs:
ASA 85(78.7%) 496(69.0%) *
Clopidogrel 49(45.4%) 160(22.3%) ***
Betablockers 85(78.7%) 577(80.3%) ns
Statins 74(68.5%) 490(68.2%) ns
Nitrates 71(65.7%) 427(59.4%) ns
NSAID 54(50.0%) 188(28.3%) ***
Laboratory findings:
Total cholesterol (mmol/l) 4.81±1.31 4.97±1.23 ns
HDL cholesterol (mmol/l) 1.08±0.76 1.29±0.60 **
LDL cholesterol (mmol/l) 2.82±1.09 2.94±1.81 ns
Triglycerides (mmol/l) 2.37±1.37 1.94±1.57 *
Coronary findings:
One-vessel disease 31(29.5%) 164(23.9%) ns
Two-vessel disease 26(24.8%) 160(23.3%) ns
Three-vessel disease 29(27.6%) 156(22.7%) ns
Left main disease 10(10.4%) 47(9.1%) ns
Normal CAG 15(14.3%) 196(28.5%) **
Type of treatment:
Pharmacotherapy 37(34.9%) 175(25.7%) *
PCI/stent 34(32.1%) 185(27.2%) ns
CABG 24(22.6%) 149(21.9%) ns
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During the follow-up period of eight years, 68 patients died, 756 survived 
and 8 were lost for follow-up. The all-cause mortality was significantly 
higher in Roma patients (χ2 = 5.93, p < 0.05). Crude all-cause mortality in 
Roma was twice that of non-Roma (hazard ratio (HR) 1.96, 95% confidence 
interval (CI) 0.91; 4.23). Adjustment for gender, age and educational level 
increased the ethnic differences (HR: 2.01, 95% CI 1.03; 3.93) (see Figure 5.1).
Figure 5.1 Kaplan-Meier curve showing the 8-year all-cause mortality of Roma and non-Roma patients who 
underwent coronary angiography adjusted for gender, age, age² and educational level (χ²=13.28, p<0.05).
Adding education (Model 3A) or medical factors (Model 3B) decreased 
the size of the ethnic difference in mortality after CAG. Functional class 
NYHA III or IV was associated with a higher risk of death (see Table 5.2). 
Both groups of factors – education and medical factors – contributed 
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Discussion
The aim of this study was to compare the all-cause mortality after CAG in 
Roma and non-Roma patients crude and adjusted for age and gender, and 
to assess whether differences in educational level, medical risk factors, 
severity of the coronary heart disease and type of treatment contributed to 
these differences in mortality. The eight-year mortality was significantly 
higher among Roma patients and remained so even after adjustment 
for age, gender and education. Male gender is a well-known risk factor 
for coronary heart disease, which in our studied population was also 
associated with an increased risk of death. The severity of the coronary 
heart disease expressed in the number of diseased vessels and the type of 
treatment had no influence on mortality after CAG. Among the medical 
factors associated with increased risk of death in Roma patients, the 
highest risks concerned functional class NYHA III. or IV.
Our findings are consistent with previous studies, which reported 
a higher prevalence of CVD risk factors and all-cause mortality in Roma 
(3,4,8,12,23). We found a worse risk-profile in Roma cardiac patients when 
undergoing CAG, similar to our previous findings (24). Babinska et al. 
also showed lower levels of HDL cholesterol, but obesity in our study 
was neither associated with increased mortality nor more frequently 
occurring in Roma cardiac patients (25). Smoking, a positive history of 
previous myocardial infarction, an abnormal CAG and the use of ASA 
were similarly associated with increased risk of death in both Roma 
and non-Roma. Regarding higher prevalence of diabetes mellitus as an 
important CVD risk factor, we did not find any differences between Roma 
and non-Roma, as was previously reported (8). 
Socioeconomic status, measured as educational level, explained only 
a part of the excess mortality in Roma CHD patients when compared with 
non-Roma CHD patients, which is in line with previous findings (15,26). 
It should be noted, however, that a very large majority of Roma had a low 
educational level (97.3%). The combination of male gender, low education 
and adverse medical factors like NYHA classes III or IV explained about 
one-half of the increased risk of death after CAG in Roma patients, only 
slightly more than those groups separately. Other factors may explain the 
remainder of excess mortality among Roma. These comprise, for example, 
behavioral and genetic differences, poor living conditions, poverty, 
discrimination, health illiteracy and language problems. Roma patients 
have also reported experiencing barriers in accessing health care services 
(27), which may cause a severe delay in access to diagnosis and treatment 
of cardiovascular diseases.
Strengths and limitations of the study
This prospective, single major cardiac center study presents unique data 
on the long-term mortality of a rather large sample of Roma patients who 
underwent CAG and on a comparison group from the majority population 
living in the same region. Another strength of this study is its relatively 
high response rate and very low loss to follow-up over the years. It is one 
of the first studies dealing with an explanation of the difference between 
Roma and non-Roma mortality in patients after CAG.
One of the limitations may be the lack of information on the exact 
cause of death in patients, making it impossible to distinguish between 
cardiac and non-cardiac mortality. In addition, we had data on just one 
indicator of socioeconomic status, i.e. education, but it should be noted 
that Roma score similarly low regarding income and occupation. 
Implications
The results of this study on all-cause mortality after CAG highlight 
that Roma ethnicity is associated with an increased risk of death when 
compared with non-Roma and explains which factors contribute to this 
difference in mortality. Improving the clinical status of Roma patients by 
modifying CVD risk factors and earlier diagnosis of CHD with adequate 
treatment may help to lower this excess mortality. More fundamentally, 
improvement of socioeconomic status in the Roma population could 
help to change the mortality differences in this minority as well. Finally, 
identification of other explanatory factors in worse Roma health outcomes 
deserves further attention in research (28). Our findings show that much 
health can be gained if their increasing mortality risk after coronary 
angiography is solved.
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Chapter 6
Does poorer self-rated health mediate 
the effect of Roma ethnicity on all-
cause mortality in patients with 
coronary artery disease after coronary 
angiography?
Adriana Sudzinova, Jaroslav Rosenberger, 
Roy E Stewart, Jitse P van Dijk, Sijmen A Reijneveld
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Abstract 
Background: The aim of this study was to assess the effect of Roma 
ethnicity and self-rated health (SRH) on nine-years all-cause mortality in 
patients with coronary artery disease (CAD) after coronary angiography 
(CAG), and whether SRH mediates the effect of ethnicity.
Methods: 623 patients (103 Roma) were included after coronary angiography 
(CAG). We obtained data from medical records and patients interviews. 
SRH was measured using the first item of the SF-36 questionnaire. A 
hierarchical Cox regression model adjusted for age, gender and education 
was used to analyze the effect of Roma ethnicity on all-cause mortality in 
CAD patients, as well as potential mediation by SRH. 
Results: Roma ethnicity and poor SRH were predictors of increased 
9-year all-cause mortality in patients with CAD, with hazard rates 
(95%-confidence intervals) being 2.34 (1.24;4.42) and 1.81 (1.02;3.21), 
respectively. Adding education decreased the size of ethnic differences 
in mortality. The mediating effect of SRH on the association of ethnicity 
with mortality was not statistically significant; neither modified ethnicity 
the effect of SRH.
Conclusion: Mortality after CAG is higher among Roma than among non-
Roma patients. Poor SRH does not mediate this higher mortality even 
though it indicates an increased risk of mortality as well. Roma patients 
with a poor SRH have thus an importantly increased risk to die after CAG. 
Keywords
mortality; coronary angiography; coronary artery disease; Roma ethnicity; 
self-rated health
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Introduction
Cardiovascular diseases (CVD) are the major cause of premature mortality 
and disability worldwide (1,2). Coronary artery disease (CAD) as one of 
the two major forms of CVD is the single most common cause of death in 
Europe, accounting for 1.8 million deaths in Europe each year (3). Death 
rates from CAD are generally higher in Central and Eastern Europe than 
in Northern, Southern and Western Europe (3). CAD represents a huge 
burden on both patients and health care systems in each European country. 
The incidence and prognosis of CAD differ by ethnicity within 
a country, Roma being one of the groups at risk. Over the last decades 
evidence has increased on ethnic inequalities in Roma population, which 
forms the biggest minority in Central and Eastern Europe (4-22). An 
estimated 5 to 10 million Roma currently live in the EU, according to 
European Parliament Resolution of 31 January 2008 (23). Estimates of the 
share of the Roma in the Slovak population vary from 2.0% according to 
the last Population and house census in the Slovak Republic in 2011(24) 
to 7.2% (approximately 380,000 Roma) according to the Institute of 
Informatics and Statistics of the Slovak Republic (25). Previous studies 
found an increased mortality and worse health status in Roma population 
(4-7,10,13,26-28). Only a part of this unfavorable health outcome can be 
explained by their lower socioeconomic status (11).
Self-rated health (SRH) is an independent predictor of increased 
mortality in patients with known CAD (29-32). Poor SRH after adjustment 
for relevant factors was shown to be associated with significantly higher 
mortality in this group of patients (29). Roma patients with coronary heart 
disease showed poorer health-related quality of life when compared to 
their non-Roma counterparts (13,18,33). However, the association of SRH 
and Roma ethnicity on all-cause mortality in CAD patients was not yet 
studied. Therefore the aim of this study was to assess the effect of Roma 
ethnicity and SRH on nine-years’ all-cause mortality in patients with 
coronary artery disease (CAD) after coronary angiography (CAG), and 
whether SRH mediates the effect of ethnicity.
Methods
Patients
A total of 1010 consecutive adult Roma and non-Roma patients who 
underwent routine elective coronary angiography (CAG) at the East 
Slovakian Institute for Cardiac and Vascular Diseases in Kosice, Slovakia, 
in the years 2004 - 2013 were asked to participate in our study (Figure 
1). The inclusion criteria were being referred for CAG and age under 75 
years. We excluded 346 patients based on the exclusion criteria - diagnosis 
of severe cognitive impairments, psychiatric disorder in the medical 
history, normal CAG, infectious endocarditis, acute myocardial infarction, 
severe valve disease, severe atrial or ventricular septal defect. Of the 
eligible patients, 41(4.2%) refused to participate, leading to inclusion of 
623 participants in the study (response rate 95.8%) (see Figure 6.1). 
Figure 6.1 Flowchart of the study population
CAG – coronary angiography
The study was approved by the Ethics Committee of the East Slovakian 
Institute for Cardiac and Vascular Diseases in Kosice in November 2004. 
All participants were provided with information about the study and 
signed an informed consent statement prior to the study. 
Procedures and measures 
Data collection consisted of an interview conducted by a psychologist or 
trained research assistant with each participant during hospitalization and 
extraction of data from medical records. Sociodemographic data included 
age, gender, education and ethnicity. We categorized education into three 
categories – low (elementary school or secondary school without school 
leaving exam), middle (secondary school with school leaving exam) and 
high (university degree). Ethnicity was measured based on each patient’s 
declaration and identification by the doctor. In case of conflicting opinions, 
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Clinical data were retrieved from the medical records. These included 
disease history, use of drugs and type of treatment after CAG. Disease 
history concerned previous myocardial infarction, arterial hypertension, 
diabetes mellitus, dyslipidaemia and the use of acetylsalicylic acid 
(ASA), clopidogrel, beta-blockers, statins, nitrates, anxiolytics and non-
steroid anti-inflammatory drugs (NSAIDs). We also asked about smoking 
status (smoker or non-smoker) and alcohol use (alcohol consumption yes 
or no). Levels of total, low density lipoprotein (LDL) and high density 
lipoprotein (HDL) cholesterol and triglycerides were registered according 
to laboratory findings. The ejection fraction was measured by ultrasound 
using either the Simpson or the occulometric method. The type of 
treatment following the CAG concerned conservative pharmacological 
treatment, percutaneous coronary intervention (PCI) or coronary artery 
bypass grafting (CABG). This was decided on by cardiologists based 
on the results of CAG and the patient’s clinical status, independently 
of participation in this study. The severity of the CAD was evaluated 
using the Canadian Cardiovascular Society (CCS) and New York Heart 
Association (NYHA) classifications. CCS identifies the severity of chest 
pain in 4 grades, NYHA classifies dyspnea symptoms in 4 grades. In both 
scales, a higher score represents worse symptomatology.
SRH was measured using the first question of the Short Form Health 
Survey (SF-36). The answer options 1 (excellent), 2 (very good), 3 (good), 
4 (fair) and 5 (poor) were transformed into two categories – good (1+2+3) 
and poor (4+5). The validity and reliability of the SF-36 scale have been 
established in patients with coronary artery disease (34).
Data on patient mortality during nine years after CAG were obtained 
from the Central Registry of the Health Care Surveillance Authority of 
the Slovak Republic.
Statistical analyses
As the first step, we assessed background and clinical characteristics of 
the Roma and non-Roma patients. Differences were statistically tested 
using the t-test for continuous variables and χ2 or Fisher exact tests, when 
appropriate, for categorical variables. Values of p<0.05 were considered 
statistically significant. 
Next, we analyzed the association of Roma ethnicity and SRH on 
all-cause mortality in CAD patients using a three-step hierarchical Cox 
regression model. Model 1 tested the effect of age, age2 (35), gender and 
ethnicity; Model 2 added education and Model 3 all above and SRH. Possible 
mediation between ethnicity and self-rated health was tested according to 
Baron and Kenny (36). All statistical analyses were performed using the 
statistical software IBM SPSS 20.0 for Windows (IBM company, Chicago, 
Illinois, USA) and Mplus 7.1 (Muthen&Muthen, Los Angeles, USA).
Results
Baseline characteristics of the study population are given in Table 6.1. There 
were 103 (16.5%) Roma and 520 (83.5%) non-Roma patients included in our 
study. Roma patients with CAD were significantly younger, with lower 
education level and smoked more frequently. No significant difference 
was found regarding SRH. They had more frequently a positive history of 
previous myocardial infarction and were more symptomatic according to 
CCS classes of angina pectoris classification. NYHA classes and ejection 
fraction were similar in both groups of patients. The Roma patients used 
significantly more frequently clopidogrel and NSAIDs. Regarding type 
of treatment after CAG, we found no significant differences between both 
groups of patients.
During the 9-years’ follow-up period 82 (13.2%) patients died, 536 
survived (86.0%) and 5 were lost to follow-up. Cox regression models 
adjusted for age, age2 and gender showed that Roma ethnicity significantly 
predicted an increased 9-year all-cause mortality (hazard ratio (HR) 2.70, 
95%-confidence intervals (CI) 1.46;4.96) (see Table 6.2). Adding education 
decreased the size of ethnic differences in mortality (HR 2.37, 95%-CI 
1.26;4.49). Adjustment for SRH did hardly affect the effect of ethnicity and 
of SRH (HR for Roma ethnicity 2.34, 95%-CI 1.24;4.42 and HR for SRH 1.81, 
95%-CI 1.02;3.21) (see Table 6.2). Additional analyses on mediation did not 
show any significant mediating effect of SRH regarding the association of 
ethnicity and mortality.
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Table 6.1 Baseline characteristics of the study population by ethnicity (N=623). All figures are numbers 
and proportions except if otherwise indicated.
* p<0.05; ** p<0.01; *** p<0.001; ns – not statistically significant; all statistically significant differences 
are indicated in bold; SD - standard deviation; BMI – body mass index; ASA – acetylsalicylic acid; NSAIDs 
– non-steroid anti-inflammatory drugs; HDL – high density lipoprotein; LDL – low density lipoprotein; PCI – 
percutaneous coronary intervention; CABG – coronary artery bypass grafting
Table 6.2 Results of Cox regression analysis of 9-years’ all-cause mortality adjusted for gender, age, age2, 
ethnicity, education and self-rated health (SRH) in a sample of Roma and non-Roma patients with coronary artery 
disease: hazard ratio (HR), 95%-confidence intervals (CI) (N=553), significance of the model change (smc).
HR 95%-CI smc
Model 1 (χ2 = 12.54)*  
ethnicity (Roma vs. non-Roma) 2.70 (1.46;4.96) **
Model 2 (χ2 = 15.92*)  *
ethnicity (Roma vs. non-Roma) 2.37 (1.26;4.49)**
education (low vs. middle and high) 1.12 (0.62;2.03)
Model 3 (χ2 = 19.87**)  *
ethnicity (Roma vs. non-Roma) 2.34 (1.24;4.42)**
education (low vs. middle and high) 1.04 (0.57;1.89)
SRH (poor vs. good) 1.81 (1.02;3.21)*
* p<0.05; ** p<0.01; *** p<0.001; ns – not significant; all statistically significant differences are indicated 
in bold; HR – hazard ratio; CI – confidence interval for HR; smc – significance of the model change; SRH – 
self-rated health
Model 1 adjusted for age, age2, gender and ethnicity
Model 2 adjusted for age, age2, gender, ethnicity and education
Model 3 adjusted for age, age2, gender, ethnicity, education and SRH
Discussion
The aim of this study was to assess the effect of Roma ethnicity and SRH 
on nine-years’ all-cause mortality in patients with CAD confirmed by 
CAG and to assess whether SRH mediates the effect of ethnicity. A more 
than 2 times higher mortality in Roma patients with CAD persisted after 
adjustment for age, age2, gender, education and SRH. SRH by itself was 
a significant predictor of mortality in Roma CAD patients, but did not 
mediate the effect of Roma ethnicity on mortality.
In previous studies, which were rather descriptive, a higher mortality 
of Roma was shown (10,26,37). The current study confirmed that Roma 
ethnicity was a strong predictor of all-cause mortality, too. Despite the 
significantly lower educational level in Roma patients with CAD, the 
ethnic differences in all-cause mortality remained after adjustment for 
education. This is in contrast with the previously described explanations 
of the differences in health status and prognosis of Roma patients by the 
lower SES of the Roma minority (10,28). 
The association of SRH and Roma ethnicity on all-cause mortality in 
CAD patients was not yet studied before. We assumed that SRH could be 
a possible mediator of the increased all-cause mortality in Roma patients, 
but this association was not confirmed in our study. We found a trend 
towards poorer SRH in Roma, but the difference was not significant, which 
is in contrast with poorer SRH in Roma described in previous studies 
(4,5,9,18,28). Regarding studies on Roma ethnicity, mortality and CAD, we 
Roma (N=103) Non-Roma (N=520) Significance of difference
Socio-demographic data:
Age (years, mean ± SD) 53.8 ± 6.8 58.9 ± 7.3 *** 
Age range (years) 35-73 32-75
Age category distribution ***
     Up to 45 9(8.7%) 22(4.2%)
     46-60 77(74.8%) 277(53.3%)
     61-75 17(16.5%) 221(42.5%)
Gender (male) 76(73.8%) 367(70.6%) Ns
Education ***
     Low education 100(97.1%) 286(55.0%)
     Middle education 2(1.9%) 88(16.9%)
     High education 1(1.0%) 146(28.1%)
Self-rated health: Ns
     Poor 59(77.6%) 323(67.0%)
     Good 17(22.4%) 159(33.0%)
BMI (kg/m²) 30.1±5.4 29.7±12.8 Ns
History of disease:
Previous myocardial infarction 68(66.0%) 271(52.1%) *
NYHA III-IV 17(20.7%) 77(22.1%) Ns
CCS IV 12(12.8%) 26(5.9%) *
Dyslipoproteinaemia 66(64.1%) 332(64.0%) Ns
Arterial hypertension 79(76.7%) 444(85.9%) *
Diabetes mellitus 34(33.0%) 190(36.5%) Ns
Smoking 34(33.3%) 55(10.6%) ***
Alcohol 61(59.2%) 367(70.6%) *
Use of drugs:
ASA 81(80.2%) 385(74.3%) Ns
Clopidogrel 48(47.5%) 134(25.9%) ***
Betablockers 82(81.2%) 435(84.0%) Ns
Statins 72(71.3%) 388(74.9%) Ns
Nitrates 68(67.3%) 331(63.9%) Ns
Anxiolytics 9(8.9%) 25(4.8%) Ns
NSAIDs 49(48.5%) 113(23.9%) ***
Laboratory findings (mean±SD):
Total cholesterol (mmol/l) 4.80±1.31 4.93±1.30 Ns
HDL cholesterol (mmol/l) 1.09±0.79 1.26±0.67 Ns
LDL cholesterol (mmol/l) 2.81±1.09 2.91±1.38 Ns
Triglycerides (mmol/l) 2.36±1.43 2.02±1.66 Ns
Ejection fraction (%, mean±SD) 49.0±11.2 50.2±9.7 Ns
Type of treatment:
Pharmacotherapy 42(40.8%) 167(32.1%) Ns
PCI/stent 34(33.0%) 196(37.7%) Ns
CABG 27(26.2%) 157(30.2%) Ns
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did not find any other study exploring the association of SRH, ethnicity 
and mortality in such a group of patients. The lack of a mediating effect 
of SRH on the association of Roma ethnicity with mortality indicates that 
Roma patients with CAD and a poor SRH have an even higher risk of 
death in long-term outcome. 
Our finding of an increased Roma mortality may be related to 
differences in baseline variation in risk profiles of the Roma and non-
Roma with CAD which are not fully captured by SRH. A worse risk 
profile regarding CVD was shown in previous studies(6,7,14,19,38). We 
might consider more severe forms of CAD at the time of CAG, as shown 
by the difference in CCS IV classes, more frequent history of the previous 
myocardial infarction and higher use of clopidogrel. Also significantly 
more smokers among Roma existed, which is an important risk factor of 
CAD. This at average worse general CAD risk profile of Roma may lead to 
a higher mortality after treatment, too.
On the other hand, this increased mortality among Roma may also 
be due to delays in their access to adequate health care because they 
experience barriers in the health care system (27). The resulting longer 
delay between symptom onset and treatment among Roma may decrease 
their survival. Barriers contributing to poorer access may be the lower 
educational level of the Roma population and low health literacy. Other 
barriers that hamper a proper access to care may be the perception of 
health care professionals that the Roma are aggressive patients, probably 
due to a low understanding of the health care process, a worse adherence 
to secondary prevention measures and medical therapy, and less 
willingness among Roma to be hospitalized due to their cultural beliefs 
and discrimination may play an important role as well (39).
Strengths and limitations of the study
The strengths of this study are its high response rate (93.8%), the relatively 
large share of Roma in the sample (16.5%), the long observation period 
and the very low loss to follow-up over the years. It is a longitudinal, 
single major cardiac center study dealing with unique long-term data on 
specific Roma ethnicity mortality. 
One of the limitations may be the lack of information on the exact 
cause of death in patients, making it impossible to distinguish between 
cardiac and non-cardiac mortality. Moreover, SES was determined only by 
education, which is just one aspect of SES, although one has to consider 
that Roma score similarly low in household income and occupation (40). 
Implications
We found that all-cause mortality after CAG is higher among Roma than 
among non-Roma patients with CAD. Poor SRH does not mediate this 
higher mortality even though it indicates an increased risk of mortality as 
well. Roma patients with a poor SRH have thus an importantly increased 
risk to die during 9 years’ follow-up after CAG. SRH as a simple method 
can be used as a predictor for death risk stratification in Roma with known 
CAD and may imply a more aggressive approach to secondary prevention 
of CAD and its complications like acute myocardial infarction or heart 
failure. Results must be verified in a larger, multicenter, cohort to allow 
for generalization. Furthermore, the pathways between psychological, 
physical and medical determinants associated with Roma ethnicity, SRH 
and mortality have to be studied in the future. This may offer cues to 
counteract the increased death rates among Roma.
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Chapter 7
Changes in clinical status, health 
behaviour and self-rated health after 
coronary angiography in Roma and non-
Roma Coronary Artery Disease patients
Adriana Sudzinova, Jaroslav Rosenberger, 
Jitse P van Dijk, Sijmen A Reijneveld
submitted
Abstract 
Background: Roma have a higher mortality after coronary angiography 
(CAG) and poorer health status at entrance into cardiological care. It is 
unclear whether poorer treatment effects contribute to this. Therefore, the 
aim of this study was to assess changes in clinical status, health behaviour 
and self-rated health (SRH) after CAG in Roma patients with coronary 
artery disease (CAD) compared with non-Roma patients.
Methods: 264 patients (25 Roma) who had undergone CAG were included 
in the study. SRH and medical data were measured at baseline and 
follow-up (12-26 months). Linear and logistic regression analyses were 
performed to assess the effect of ethnicity on the outcome variables over 
the follow-up period.
Results: Triglycerides and diastolic blood pressure increased significantly 
in Roma when compared with non-Roma during the follow-up (OR with 
95% CI: -1.96 (-3.80, -0.11) and 17.55 (3.72, 31.37), respectively). No other 
significant differences in improvement between Roma and non-Roma 
were found.
Conclusion: The poorer outcomes of Roma CAD patients are for the most 
part not due to less improvement of their clinical status, health behaviour 
and SRH after CAG. Outcomes may thus be improved in particular by 
enhancement of access to health care.
Keywords
clinical status; medical risk factors; self-rated health; coronary angiography; 
coronary artery disease; Roma ethnicity
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Introduction
Roma represent one of the largest minorities across Central and Eastern 
Europe, and their health status is relatively poor. Estimates of their numbers 
vary from 5 to 10 million according to a European Parliament Resolution 
from 31 January 2008 (1). In Slovakia Roma account for approximately a 
2-7% share of the entire Slovak population, which means 105,000 to 380,000 
Roma (2,3). Research published in recent years has shown that Roma 
ethnicity is associated with a worse risk profile regarding cardiovascular 
risk factors  like smoking, dyslipidaemia, diabetes and obesity(4-13). 
Moreover, previous studies also found an increased mortality in Roma 
(14-18). Of particular relevance to the Roma context is their generally low 
socioeconomic status, which may affect their health outcomes (5,19-22). 
Roma on average have a very low education level and face high rates of 
unemployment (23,24).
Roma patients with coronary artery disease (CAD) have been shown 
to have poorer outcomes after treatment when compared with their non-
Roma counterparts. In CAD patients, Roma ethnicity was associated with 
a worse risk profile, more severe forms of CAD, poorer health-related 
quality of life and higher all-cause mortality (13,18,25,26). Thus, Roma are 
considered to be a high-risk population for cardiovascular diseases, which 
are the leading cause of mortality, morbidity and disability worldwide 
(27,28). 
Ethnic differences regarding the improvement of the health status 
after the treatment of CAD in the Roma population have not yet been 
studied. Like the worse risk profile of Roma at entry to health care, 
such differences in improvement might contribute to the poorer health 
outcomes of the Roma patients. Therefore, the aim of this study was 
to assess the changes in clinical status, health behaviour and self-rated 
health (SRH) after coronary angiography (CAG) in Roma patients with 
CAD compared with non-Roma patients.
Methods
Patients
A total of 923 consecutive adult Roma and non-Roma patients who 
underwent routine elective coronary angiography (CAG) at the East 
Slovakian Institute for Cardiac and Vascular Diseases in Kosice, Slovakia, 
in the years 2004 - 2012 were asked to participate in our study (Figure 1). 
The inclusion criteria were being referred for CAG and age under 75 years. 
We excluded 217 patients based on the exclusion criteria: diagnosis of 
severe cognitive impairments, psychiatric disorder in the medical history, 
normal CAG, infectious endocarditis, acute myocardial infarction, severe 
valve disease, severe atrial or ventricular septal defect. Of the eligible 
patients, 127 refused to participate, resulting in a response rate 82%. From 
the remaining 579 patients who were invited for follow-up 12-26 months 
after CAG, 14 patients died during the follow-up period. We also excluded 
85 patients who came for follow-up earlier than 12 months or later than 
26 months after CAG. Ultimately, 264 patients who came for follow-up 
(response rate 64%) were included in the study (see Figure 7.1). 
Figure 7.1 Flowchart diagram of the study population
CAG – coronary angiography
The study was approved by the Ethics Committee of the East Slovakian 
Institute for Cardiac and Vascular Diseases in Kosice in November 2004. 
All participants were provided with information about the study and 
signed an informed consent statement prior to the study. 
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Procedures and measures 
Data collection consisted of two measurements: a baseline measurement 
(the day preceding the CAG) and a follow-up examination (12-26 months 
later). During the baseline measurement, a cardiologist extracted data 
from medical records and performed a physical examination of the patient, 
including blood pressure and heart rate measurements. An interview was 
conducted with each participant by a psychologist or trained research 
assistant. Percutaneous coronary intervention with or without stent 
implantation (PCI) was performed immediately after CAG, and surgical 
revascularization followed on average 50±43days after CAG. For the 
follow-up examination patients were invited via postal mail. During the 
follow-up the same type of interview as at the time of enrollment was 
conducted, as well as a physical examination of the patient, with extraction 
of data from medical records performed by a cardiologist. 
Sociodemographic data included age, gender, education and 
ethnicity. We categorized education into three categories – low 
(elementary school or secondary school without school leaving exam), 
middle (secondary school with school leaving exam) and high (university 
degree). Ethnicity was measured based on each patient’s declaration and 
identification by the doctor. In case of conflicting opinions, an independent 
third person (a head-nurse) was decisive. 
Clinical data were retrieved from the medical records. These included 
disease history, use of drugs and type of treatment after CAG. Disease 
history concerned previous myocardial infarction, arterial hypertension, 
diabetes mellitus, dyslipidaemia and the use of acetylsalicylic acid (ASA), 
clopidogrel, betablockers, statins, nitrates, anxiolytics and non-steroid 
anti-inflammatory drugs (NSAID). We also asked about smoking status 
(smoker or non-smoker) and alcohol use (alcohol consumption yes or 
no). Levels of total, low-density lipoprotein (LDL) and high-density 
lipoprotein (HDL) cholesterol and triglycerides were registered according 
to laboratory findings. The ejection fraction was measured by ultrasound 
using either the Simpson or the occulometric method. The type of 
treatment following the CAG concerned conservative pharmacological 
treatment, PCI or coronary artery bypass grafting (CABG). This was 
decided on by cardiologists based on the results of CAG and the patient’s 
clinical status, independently of participation in this study. The severity 
of the CAD was evaluated using the Canadian Cardiovascular Society 
(CCS) and New York Heart Association (NYHA) classifications. CCS 
identifies the severity of chest pain in 4 grades, while NYHA classifies 
dyspnea symptoms in 4 grades. In both scales, a higher score represents 
worse symptomatology. We measured the physical status by taking into 
our analysis the worst grade from either the NYHA or CCS classification 
in each patient.
SRH was measured using the first question of the Short Form Health 
Survey (SF-36) (29). The answer options 1 (excellent), 2 (very good), 3 
(good), 4 (fair) and 5 (poor) were transformed into two categories – good 
(1+2+3) and poor (4+5). The validity and reliability of the SF-36 scale has 
been proven in patients with coronary artery disease (30).
Statistical analyses
As the first step, we described the background and clinical characteristics 
of the Roma and non-Roma patients. Differences were statistically tested 
using the t-test or Mann-Whitney U-test for continuous variables and χ2 or 
Fisher exact tests, when appropriate, for categorical variables. Values of 
p<0.05 were considered statistically significant. Next, changes over time 
were tested using paired t-tests or related-samples Wilcoxon signed-rank 
tests for continuous variables and χ2 square tests or McNemar tests for 
categorical variables, as appropriate. Finally, linear and logistic regression 
analyses were performed to assess the effect of ethnicity on changes in the 
outcome variables over the followed period of time.
All statistical analyses were performed using the statistical software 
program PASW SPSS version 20.0 for Windows (SPSS Inc., Chicago, 
Illinois, USA).
Results
Baseline characteristics of the study population are given in Table 7.1. Roma 
patients were significantly younger, had lower education, were more obese 
and smoked more frequently when compared with non-Roma. Roma 
patients more frequently had a positive history of previous myocardial 
infarction and more frequently used clopidogrel or betablockers. The two 
groups of patients did not differ significantly in gender, SRH, presence 
of arterial hypertension, diabetes mellitus, dyslipoproteinemia, use of 
alcohol, ejection fraction and type of treatment after CAG.
When analyzing changes in the medical risk factors during the 
follow-up in each group of patients separately, we found that both Roma 
and non-Roma patients significantly improved in their functional status 
(see Table 7.2). Non-Roma patients showed a significant increase in their 
BMI, but on the other hand the levels of total cholesterol and triglycerides 
were significantly lower at the time of the follow-up. The use of clopidogrel 
significantly decreased in non-Roma patients, and the proportion of non-
Roma patients using statins and betablockers significantly increased. SRH 
significantly improved only in the non-Roma patients after CAG.
Assessment of the degree to which ethnicity modified improvements 
in the outcomes by time in linear and logistic regression analyses yielded 
no significant differences between Roma and non-Roma, except for 
triglycerides and diastolic blood pressure (Table 7.2). Triglycerides and 
diastolic blood pressure increased significantly more in Roma patients 
when compared with non-Roma.
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Table 7.1 Baseline characteristics of the study population by ethnicity (N=264). All figures are numbers 
and proportions except when otherwise indicated.
* p<0.05; ** p<0.01; *** p<0.001; ns – not significant; SD - standard deviation; BMI – body mass index; 
ASA – acetylsalicylic acid; NSAID – non-steroid anti-inflammatory drugs; HDL – high-density lipoprotein; LDL 
– low-density lipoprotein; PCI – percutaneous coronary intervention; CABG – coronary artery bypass grafting
Roma (N=25) Non-Roma (N=239) Significance of difference
Sociodemographic data:
Age (years, mean ± SD) 52.3 ± 6.0 57.4 ± 7.1 *** 
Age range (years) 35-64 32-72
Gender (male) 20 (80.0%) 185 (77.4%) ns
Education ***
     Low education 24 (96.0%) 129 (54.0%)
     Middle education 1 (4.0%) 44 (18.4%)
     High education 0 (0%) 66 (27.6%)
Self-rated health:
     Poor 11 (57.9%) 139 (61.0%) ns
     Good 8 (42.1%) 89 (39.0%) ns
BMI (kg/m²) 30.7±4.3 28.8±3.7 *
History of disease:
Previous myocardial infarction 20 (80.0%) 121 (50.6%) **
NYHA III-IV 4 (21.1%) 25 (18.0%) ns
CCS IV 2 (8.3%) 8 (4.0%) ns
Dyslipoproteinaemia 17 (68.0%) 149 (62.6%) ns
Arterial hypertension 21 (84.0%) 201 (85.2%) ns
Diabetes mellitus 6 (24.0%) 73 (30.5%) ns
Smoking 7 (28.0%) 25 (10.5%) *
Alcohol 21 (84.0%) 179 (74.9%) ns
Use of drugs:
ASA 19 (82.6%) 173 (72.7%) ns
Clopidogrel 12 (52.2%) 52 (21.8%) **
Betablockers 23 (100.0%) 199 (83.6%) *
Statins 19 (82.6%) 177 (74.4%) ns
Nitrates 18 (78.3%) 156 (65.5%) ns
Anxiolytics 3 (13.0%) 9 (3.8%) ns
NSAID 6 (25.0%) 39 (18.7%) ns
Laboratory findings (mean±SD):
Total cholesterol (mmol/l) 4.69±1.14 4.90±1.09 ns
HDL cholesterol (mmol/l) 1.06±0.51 1.28±0.58 ns
LDL cholesterol (mmol/l) 2.67±1.11 2.87±0.98 ns
Triglycerides (mmol/l) 2.60±1.91 1.96±1.69 ns
Ejection fraction (%,mean±SD) 52.5±11.1 49.7±9.6 ns
Type of treatment:
Pharmacotherapy 9 (36.0%) 65 (27.2%) ns
PCI/stent 10 (40.0%) 87 (36.4%) ns












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The aim of this longitudinal study was to assess whether Roma and non-
Roma differ regarding improvement in clinical status, health behaviours 
and SRH after CAG. We found that changes over time were mostly similar, 
with Roma patients showing significantly less improvement only in the 
levels of triglycerides and diastolic blood pressure when compared with 
non-Roma. We found no significant changes in other risk factors, such as 
smoking, BMI, systolic blood pressure, total, LDL and HDL cholesterols, 
as well as use of drugs and SRH during the follow-up.
As described in previous studies, the health status of Roma patients 
entering the health care system is rather poor when compared with the 
majority population (4,5,11,13). Their higher mortality after treatment was 
mostly explained by their worse health status after treatment and low SES 
(14,15,31,32), but no data were available on the effects of the treatment 
on these ethnic differences. The finding of no significant difference in 
improvement between Roma and non-Roma CAD patients after CAG 
indicates that the origin of these differences is already present at entrance 
into the health care system – the process of further care does not seem to 
be affected by ethnic differences.
Roma and non-Roma patients in our study did not differ in the use of 
drugs during the follow-up period, so their different outcomes are unlikely 
to be caused by a lack of adequate drug treatment after confirmation of 
the CAD by CAG. Despite facing barriers in accessing health care (21,33), 
especially in the group of Roma people living in segregated settlements, 
we can assume that their medical treatment afterwards is similar to that 
of the majority population. However, previously described differences in 
the risk profile of Roma CAD patients undergoing CAG and more severe 
forms of CAD (13) might lead to the conclusion that other factors, like late 
referral for diagnostics and treatment of CAD, are factors influencing this 
health care consumption pattern. The care process does not seem to be 
able to counteract the worse initial condition of Roma patients.
To summarize, the results of the present study suggest that the lack 
of ethnic differences in changes of clinical status, health behaviour and 
SRH after CAG between Roma and non-Roma CAD patients may exclude 
these factors as being responsible for the worse outcomes of the Roma 
CAD patients. Other factors at entry to care, i.e. before undergoing CAG, 
must therefore be considered.
Strengths and limitations
To our knowledge, this is the first single major center longitudinal study 
focusing on a specific Roma population with diagnosed CAD and the 
changes in clinical status, health behaviour and SRH. However, one of the 
limitations of our study is the relatively small number of Roma patients, 
which might be responsible for some non-significant results. Next, we did 
not adjust the regression analysis of changes for possible confounding 
factors like age or education because we had already adjusted for them 
at baseline.
Implications
The present finding of almost no significant changes in the clinical status, 
health behaviour and SRH between Roma and non-Roma CAD patients 
implies for health researchers and health policy makers that they should 
direct their future research efforts on identifying the underlying causes. 
Health care practitioners and cardiologists should consider Roma patients 
for earlier referral for CAG to diagnose CAD at earlier stage of the disease. 
In this way, their later unfavorable outcomes might be improved. Special 
attention should be paid on treatment of hypertriglyceridemia by non-
pharmacologic measures, such as lifestyle changes in Roma CAD patients. 
Future research should look to determine what causes the delay at entry 
into care of Roma CAD patients.
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The aim of this thesis was to explore the association between Roma 
ethnicity and the outcomes of coronary artery disease (CAD) in patients 
undergoing coronary angiography (CAG). First, this thesis focused on the 
relationship of Roma ethnicity, medical risk factors and the severity of CAD 
at entry to cardiologic care compared with non-Roma. Next, it assessed 
ethnic differences in mortality after treatment and changes in clinical 
status, health behaviour and self-rated health (SRH) over the follow-up 
period. Furthermore, this thesis aimed to provide an explanation of ethnic 
differences in all-cause mortality in patients after CAG and looked for 
effects of Roma ethnicity on mortality and SRH.
In this final chapter the main findings will be summarized (8.1) and 
discussed within the context of the current status in the field of interest 
(8.2). Next, the strengths and limitations of the thesis will be addressed 
(8.3). Finally, the chapter will be completed with implications for practice 
and recommendations for future research (8.4).
8.1  Main findings
Research question 1 Do Roma coronary heart disease patients have more 
medical risk factors and greater severity of coronary heart disease than non-
Roma?
Roma patients had significantly more risk factors and more severe types of 
coronary heart disease (CHD) at entry to cardiologic care than non-Roma. 
They were treated less frequently with statins and beta-blockers and were 
more frequently left on pharmacotherapy and surgically revascularized. 
These differences remained after controlling for education, gender and 
age. Thus, Roma CHD patients have a worse risk profile at entry to care 
and seem to be under-treated in the period before entry compared with 
non-Roma CHD patients.
Research question 2 What is the seven years’ mortality in Roma and non-
Roma patients after coronary angiography?
The seven years’ all-cause mortality after CAG was significantly higher 
among Roma than among non-Roma, and differences decreased only 
partially after adjustment for educational level, gender and age. Thus, the 
higher mortality after CAG among Roma can only partially be explained 
by the lower socioeconomic status of this minority.
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Research question 3 What causes the difference in eight years’ mortality of 
Roma and non-Roma patients after coronary angiography?
The eight years’ all-cause mortality after CAG was significantly higher 
among Roma than among non-Roma after adjustment for age, gender, 
education, severity of the CAD and type of treatment. Among the 
medical factors associated with increased risk of death in Roma patients, 
the highest risks concerned functional classes NYHA III or IV. The excess 
of Roma mortality after CAG can be partially explained by their lower 
education and worse clinical status. 
Research question 4 Does poorer self-rated health mediate the effect of Roma 
ethnicity on mortality in patients with coronary artery disease after coronary 
angiography?
We found that both Roma ethnicity and poor SRH were predictors of 
increased nine years’ all-cause mortality in patients with CAD, also 
adjusted for differences in educational level. Poor SRH did not mediate 
the higher mortality among Roma CAD patients. Roma patients with a 
poor SRH thus have a significantly increased risk of dying after CAG.
Research question 5 What are the changes in clinical status, health behavior 
and self-rated health after coronary angiography in Roma and non-Roma coronary 
artery disease patients?
We found no significant differences in improvement after CAG of clinical 
status, health behaviour and SRH between Roma and non-Roma, except for 
triglycerides and diastolic blood pressure. The higher mortality after CAG 
in Roma CAD patients is therefore mainly not due to less improvement of 
their clinical status, health behaviour and SRH after CAG. Their outcomes 
may in particular be improved by enhancement of their access to health 
care earlier than when it comes to CAG.
8.2  Discussion of the main findings
The main findings will be discussed within the framework of the general 
aims, as outlined in the model in Chapter 1. Our main findings are 
summarized in Figure 8.1.
Figure 8.1 Model of the relationships examined in the thesis and findings on these, regarding CAG referred 
patients
CAD – Coronary artery disease; CAG – coronary angiography; RQ – research question; 
- sign indicates a significant negative influence of Roma ethnicity on the explored relationship
We found ethnic differences in the outcomes of CAD patients after 
specialized cardiologic care at the disadvantage of Roma. This might be 
due to either a poorer health status at entry or to less improvement after 
entry into care, including differences in the quality of the treatment, or 
their combination.
Regarding the poorer outcomes of Roma, one of our main findings 
is a higher all-cause mortality in Roma CAD patients (1), which is in 
line with previous studies that found a generally higher mortality in the 
Roma population (2-6). Differences were found in the mortality among 
other ethnicities, as well (7,8). Borrell et al. observed the mortality to 
be lower among Hispanic women than among non-Hispanic white 
women (9). On the other hand, Feder et al. did not find any difference 
in mortality between south Asian and white participants among patients 
appropriate for revascularization, though South Asians were less likely 
to receive CABG (10). Van Oeffelen showed a decline in the incidence of 
acute myocardial infarction in all ethnic groups, except in Turkish women 
and Moroccan men in the Netherlands during the past decade (11,12). 
Differences in the incidence of the medical risk factors of CAD among 
various ethnicities were found as well, mostly at the disadvantage of the 
ethnic minority groups (13,14). Regarding the higher mortality in Roma, 
most studies were rather descriptive and did not look further into the 
pathways leading to this increased mortality. Such an increased mortality 
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of Roma may in general be due to a higher incidence of underlying 
diseases, a higher mortality (lethality in case of those diseases), or both. 
We here in particular assessed the lethality in CAD patients. 
We found no major differences in outcomes of treatment between 
Roma and non-Roma, suggesting that poorer quality of treatment mostly 
does not explain the higher mortality of Roma after CAD treatment. In 
particular, we looked at changes in the health status and SRH of Roma 
and non-Roma patients during the treatment process after CAG. We 
found no ethnic differences in improvement of the health status and SRH 
in Roma CAD patients after CAG when compared with non-Roma. This 
suggests that the beginning of these differences fully lies before entry into 
the health care process. Poorer treatment of Roma patients, e.g. because 
of discrimination during the treatment process, is thus unlikely, at least 
as far as treatment outcomes are concerned. However, adherence to 
treatment in Roma patients is generally poorer than in non-Roma; e.g. 
Roma are frequently unwilling to quit smoking even though they have a 
diagnosed CAD. Despite this lower adherence, their treatment outcomes 
do not differ that much from the outcomes of non-Roma, so this poor 
adherence does not seem to play an important role in Roma CAD patients.
A second pathway leading to poorer outcomes after CAD would be 
poorer health status at entry to care. We found as support for this pathway 
that Roma patients entering specialized cardiologic care did indeed have 
worse health status when compared with their non-Roma counterparts 
(15). Roma had on average a worse risk profile, which has been described 
in other studies as well (16-25). This is undoubtedly one of the main 
contributing factors for their later poorer outcomes when compared with 
the non-Roma majority population. Similar findings concerning health 
status of Roma with chronic kidney disease were described by Kolvek 
(26,27) and Rosenberger (28). This shows that the health status of Roma at 
entry to care indeed deserves further research on its causes.
One of the reasons for this poorer health status at entry to cardiologic 
care might be the low socioeconomic status (SES) of Roma. They have 
a mostly low educational level and rates of long-term unemployment 
among them are high. Moreover, many Roma, especially those residing in 
segregated settlements, live in bad housing conditions and practice poor 
nutrition. They have limited financial means for transportation, which may 
also limit their access to health care (29-31). Some authors have declared 
that this poor SES is the only cause of their bad prognosis (32). However, 
we found that even after adjustment for age, gender and education, Roma 
had a more than two-times higher risk of dying after CAG. This indicates 
that SES, as far as captured by low education, explains only a part of 
the higher mortality of Roma. The delayed access to care, which seems 
to occur at the stage in the care-seeking process, contributes most to the 
increased mortality. 
Another cause for the poorer health status of Roma at entry to 
cardiologic care may concern delays in their access to adequate health 
care because they experience barriers in the health care system (33,34). 
This may be due to the lower educational level of the Roma population 
combined with lower health literacy in particular. Another issue closely 
attached to this is the attitude of Roma towards their own health. 
Studies comparing Roma and non-Roma showed that Roma perceive the 
relationship between lifestyle and health much less as being strictly causal 
(35,36). Roma usually look for health care when they are in much worse 
health status than non-Roma, and they are generally less willing to be 
hospitalized due to their cultural beliefs (29). The resulting longer delay 
between symptom onset and treatment among Roma may decrease their 
survival.
We found SRH to be a predictor of increased mortality in all CAD 
patients, including Roma, thus confirming previous findings in CAD 
patients (37). On average, Roma have poorer SRH (38-42); however SRH 
does not mediate this higher mortality in Roma CAD patients. Thus, the 
combination of Roma and poor SRH may be used to identify patients 
most at risk of mortality.
8.3  Strengths and limitations
The strengths of the present study are its relatively high response rate at 
baseline, recruitment from a full catchment area, i.e. the east Slovakian 
region, and the large sample of Roma patients with CAD, which is unique 
in this field of research. Another strength of the study is that besides cross-
sectional data we also obtained longitudinal data. Regarding mortality, 
we had a long observation period of up to nine years and a very low loss 
to follow-up. This allowed us to assess factors associated with increased 
Roma mortality in comparison with non-Roma mortality more precisely.
However, in interpreting our results one has to consider certain 
limitations. A first limitation is the assessment of Roma ethnicity, which 
was based on each patient’s declaration and identification by the doctor, 
which could be biased. Some Roma do not declare themselves as Roma, 
but as Slovak or Hungarian. We tried to solve this problem by using a 
third opinion from a head-nurse for all patients, but this procedure may 
have missed some instances of misclassification of ethnicity. If so, that will 
probably have led to an underestimate of the real effects.  
Another limitation was the lack of information on the exact cause of 
death in patients, making it impossible to distinguish between cardiac and 
non-cardiac mortality. Ethnic differences in these patients are probably 
most pronounced for the former category. Other diseases like infectious 
diseases and chronic obstructive pulmonary disease might influence 
the mortality in Roma patients as well. Moreover, socioeconomic status 
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(SES) was determined only by education, which is just one aspect of SES. 
However, one has to consider that Roma score similarly low in household 
income and occupation.  
Furthermore, we cannot exclude a selection bias at baseline 
measurements and at follow-up. We collected data from all consecutive 
patients hospitalized at the East Slovakian Institute for Cardiac and 
Vascular Diseases, but we had no data from other cardiologic patients 
from out-patients clinics. We do not expect a significant bias due to the 
lack of economic sources in Roma patients, because health care insurance 
in Slovakia covers the entire population. Finally, it should be noted that 
our results cannot be generalized to the whole population of CAD patients 
but only to those who were referred for CAG.
8.4  Implications for clinical practice and policy, and for future 
research
We found that Roma patients had a poorer health status at entry to 
cardiologic care, which implies first, that clinicians should be aware of 
this poorer average health status and adapt their health care process to it. 
Second, general practitioners, cardiologists and physicians treating Roma 
patients with CAD should be aware of the ethnic differences in the basic 
risk profile and outcomes of these patients. These facts should urge them 
to refer Roma patients for diagnostics and adequate treatment of CAD 
earlier than they do at present. Initiatives like Roma health assistants, 
who are already working in segregated Roma settlements (29), might 
counteract the effect of low health literacy in the Roma population and 
explain to Roma patients how to influence the main risk factors of CAD 
by changing their lifestyle. 
Another implication for practice from our study is that SRH could be 
used as a simple predictor of mortality in Roma CAD patients at the time 
of CAG. This could draw further attention to Roma patients with poor 
SRH and may be easily implemented in routine practice.
Health policy makers might consider measures aimed at 
improving the access of Roma patients to the health care system, such as 
transportation free of charge, which is already available in all acute cases, 
but which might be a problem in all non-acute patients who are in need 
of an out-patients visit. A wider and more complicated issue is, of course, 
improvement of the socioeconomic status of the whole Roma population 
by increasing the educational level and decreasing unemployment (29,30). 
Our finding of a poorer cardiovascular status at entry to cardiologic care 
might warrant a screening for basic cardiovascular risk factors in this 
high-risk Roma population, with initiation of earlier treatment when 
needed. Better early detection could prevent future complications of the 
disease and could improve the prognosis of these patients. Finally, access 
to care and adherence to treatment of Roma patients might be improved 
by addressing their skills in navigating through care and by adapting care 
to their needs. Routes for the latter may be, e.g. the use of pictures and 
short films to explain symptoms and reasons for treatment, see: www.
irohla.eu. 
Researchers should focus their research interest on the delay in 
accessing the health care system present in Roma patients and design 
studies dealing with this problem. The causes of this delay might be low 
health literacy, cultural beliefs among the Roma population, a lack of 
material means for health care expenditures or others. Moreover, future 
research on Roma and CAD should also be extended to other forms of 
CAD, like acute coronary syndromes with ST elevation myocardial 
infarction and non ST elevation myocardial infarction, in order to cover all 
patients with CAD. We can assume that these forms might be associated 
with certain inequalities in the Roma population as well, even though no 
study dealing with this topic has yet to be conducted. Ethnic inequalities 
in CAD with regard to Roma were shown to have an influence on the 
prognosis of these patients. Yet, other factors that contribute to these 
differences need to be identified and studied in larger populations.
Furthermore, a comparison of the Roma population from Slovakia 
with Roma populations from other Central and Eastern European 
countries could generate new knowledge about factors that predispose 
them to poor health outcomes (43). Thus, an international study designed 
to identify these factors might help to fill in the gaps with missing 
information.
8.5  Conclusion
We conclude that Roma ethnicity in CAD is associated with worse 
outcomes. Roma CAD patients entering specialized cardiologic care have 
a significantly worse health status than their non-Roma counterparts. The 
long-term mortality in Roma patients after CAG is about twice as high 
as the mortality of non-Roma patients, and this is not due to age, gender 
or education. The lack of ethnic differences in improvement of the health 
status and SRH in Roma CAD patients after CAG when compared with 
non-Roma suggests that the origin of these differences fully lies before 
entry into the health care process. The delay in accessing health care by 
Roma patients has to be investigated in future research. We hope that this 
thesis will contribute to a better understanding of the differences in the 
outcomes of Roma CAD patients.
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Summary
The aim of this thesis was to explore the association between Roma 
ethnicity and the outcomes of coronary artery disease (CAD) in patients 
undergoing coronary angiography (CAG). First, this thesis focused on the 
relationship of Roma ethnicity, medical risk factors and the severity of 
CAD at entry to cardiologic care. Next, it assessed ethnic differences in 
mortality after treatment and changes in clinical status, health behaviour 
and self-rated health (SRH) over the follow-up period. Furthermore, this 
thesis aimed to provide an explanation of ethnic differences in all-cause 
mortality in patients after CAG and looked for effects of Roma ethnicity 
on mortality and SRH. 
In the first introductory chapter, the definition and epidemiology 
of CAD, its lethality and the medical risk factors and other factors that 
contribute to it are described. Next, Roma ethnicity in the context of CAD 
are discussed, in particular the differences between Roma and non-Roma 
regarding risks for CAD. Research questions are then formulated and 
linked to the model that is behind this thesis. The chapter ends with an 
outline of the thesis.
Chapter 2 provides information about the design of the study. It 
describes the data collection, the study population and the measures used 
in this thesis. Furthermore, it briefly describes the statistical analyses used.
Chapter 3 explores the differences in the medical risk factors and 
severity of CAD in Roma and non-Roma patients. Roma patients had 
significantly more risk factors and more severe types of coronary heart 
disease (CHD) at entry to cardiologic care than non-Roma. They were 
treated less frequently with statins and beta-blockers and were more 
frequently left on other pharmacotherapy and surgically revascularized 
after controlling for differences in educational level, gender and age. 
Thus, Roma CHD patients have a worse risk profile at entry to care and 
seem to be under-treated in the period before entry compared with non-
Roma CHD patients.
In Chapter 4 the mortality after CAG in Roma and non-Roma 
patients was assessed. The seven years’ all-cause mortality after CAG was 
significantly higher among Roma than among non-Roma, and differences 
decreased only partially after adjustment for differences in educational 
level, gender and age. Thus, the higher mortality after CAG among Roma 
can only partially be explained by the lower socioeconomic status of this 
minority.
Chapter 5 determines the difference in the eight years’ mortality 
between Roma and non-Roma patients after CAG. This mortality was 
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significantly higher among Roma than among non-Roma after adjustment 
for differences in educational level, age, gender, severity of the CAD and 
type of treatment. Among the medical factors associated with an increased 
risk of death in Roma patients, the highest risks concerned functional 
classes NYHA III and IV. The excess of Roma mortality after CAG can 
be partially explained by their lower education and worse clinical status. 
In Chapter 6 the association of self-rated health (SRH), Roma 
ethnicity and mortality after CAG in CAD patients was explored. We 
found that both Roma ethnicity and poor SRH were predictors of increased 
nine years’ all-cause mortality in patients with CAD, also adjusted for 
differences in educational level. Poor SRH did not mediate the higher 
mortality among Roma CAD patients. Roma patients with a poor SRH 
thus have a significantly increased risk of dying after CAG.
Chapter 7 deals with the changes in clinical status, health behaviour 
and SRH after CAG in Roma and non-Roma CAD patients. We found no 
significant differences in improvement after CAG of clinical status, health 
behaviour and SRH between Roma and non-Roma, except for triglycerides 
and diastolic blood pressure. The higher mortality after CAG in Roma 
CAD patients is therefore mainly not due to less improvement of their 
clinical status, health behaviour and SRH after CAG. Their prognosis may 
in particular be improved by enhancement of their access to health care 
regarding CAG.
Finally, in Chapter 8 all of the findings are summarized and 
discussed in the context of existing knowledge and the theoretical model. 
Implications for practice and future research are then indicated. We found 
that Roma ethnicity in CAD is associated with worse outcomes. Roma CAD 
patients entering specialized cardiologic care have a significantly worse 
health status than their non-Roma counterparts. The long-term mortality 
in Roma patients after CAG is about twice as high as the mortality of non-
Roma patients, and we found this is not due to age, gender, education or 
treatment after CAD. The lack of ethnic differences in improvement of the 
health status and SRH in Roma CAD patients after CAG when compared 
with non-Roma suggests that the origin of these differences lies fully in 
the trajectory before entry into the health care process. These facts should 
urge physicians, general practitioners and cardiologists to refer Roma 
patients for diagnostics and adequate treatment of CAD earlier than they 
do today. SRH could be used as a simple predictor of mortality in Roma 
CAD patients at the time of CAG. The delay in accessing health care by 
Roma patients must be investigated in future research. We hope that this 
thesis will contribute to a better understanding of the relatively poor 
prognosis for Roma CAD patients.
	 summary
Samenvatting
Het doel van dit proefschrift was om het verband te verkennen tussen Roma 
etniciteit en de uitkomsten van coronaire hartziekten (CAD) bij patiënten 
die een coronaire angiografie (CAG) hebben ondergaan. Allereerst richt 
dit proefschrift zich op de relatie tussen de Roma etniciteit, medische 
risicofactoren en de ernst van de CAD bij binnenkomst in de cardiologische 
zorg . Vervolgens werden etnische verschillen in sterfte na de behandeling 
en de veranderingen van de klinische status, gezondheidsgedrag en 
ervaren gezondheid  over de follow-up periode onderzocht. Verder  is dit 
proefschrift gericht op een verklaring van etnische verschillen in sterfte 
aan alle doodsoorzaken bij patiënten na CAG en tenslotte onderzocht het 
de effecten van Roma etniciteit op mortaliteit en ervaren gezondheid.
In het eerste inleidende hoofdstuk worden de definitie en de 
epidemiologie van CAD, de letaliteit ervan en de medische risicofactoren 
en andere factoren die eraan bijdragen beschreven. Vervolgens wordt 
Roma etniciteit in het kader van CAD besproken, met name de verschillen 
tussen Roma en niet-Roma wat betreft het risico hierop. Onderzoeksvragen 
worden vervolgens geformuleerd en gekoppeld aan het model waarop dit 
proefschrift is gebaseerd. Het hoofdstuk eindigt met een overzicht van de 
inhoud van het proefschrift.
Hoofdstuk 2 geeft informatie over de opzet van het onderzoek. 
Het beschrijft de gegevensverzameling, de onderzoekspopulatie en de 
meetinstrumenten die in dit proefschrift worden gebruikt. Bovendien 
beschrijft het kort de gebruikte statistische analyses.
Hoofdstuk 3 onderzoekt de verschillen in medische risicofactoren 
voor en de ernst van de CAD bij Roma en niet-Roma patiënten. Roma 
patiënten hadden significant meer risicofactoren en ernstiger vormen van 
de coronaire hartziekte (CHD) bij binnenkomst in de cardiologische zorg 
dan niet-Roma. Ze werden minder vaak met statines en beta-blokkers 
behandeld, werden vaker behandeld met andere farmacotherapie 
en chirurgisch gerevasculariseerd na correctie voor verschillen in 
opleidingsniveau, geslacht en leeftijd. Roma CHD patiënten hebben dus 
al bij binnenkomst in de cardiologische zorg een slechter risicoprofiel 
en lijken onderbehandeld te zijn in de periode vóór binnenkomst in 
vergelijking met niet-Roma CHD patiënten.
In hoofdstuk 4 werd de mortaliteit na CAG bij Roma en niet-Roma 
patiënten onderzocht. De zeven-jaars sterfte na CAG ten gevolge van alle 
doodsoorzaken was significant hoger bij Roma dan bij niet-Roma, en de 
verschillen verminderden slechts gedeeltelijk na correctie voor verschillen 
in opleidingsniveau, geslacht en leeftijd. De hogere mortaliteit na CAG 
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onder Roma kan derhalve slechts ten dele worden verklaard door de 
lagere sociaal-economische status van deze minderheidsgroep.
Hoofdstuk 5 bepaalt het verschil in acht-jaars sterfte tussen Roma 
en niet-Roma patiënten na CAG. Deze mortaliteit is significant hoger bij 
Roma dan bij niet-Roma na correctie voor verschillen in opleidingsniveau, 
leeftijd, geslacht, ernst van de CAD en type behandeling. Binnen de 
medische factoren die samenhangen met een verhoogd risico op overlijden 
bij Roma patiënten betrof het hoogste risico de functionele NYHA klassen 
III en IV. De over-sterfte onder Roma na CAG kan maar gedeeltelijk worden 
verklaard door hun lagere opleiding en slechtere klinische toestand.
In hoofdstuk 6 wordt het verband tussen ervaren gezondheid 
(SRH), Roma etniciteit en sterfte na CAG in CAD-patiënten onderzocht. 
We vonden dat zowel Roma etniciteit als een slechte ervaren gezondheid 
voorspellers waren van een verhoogde negen-jaars sterfte aan alle 
doodsoorzaken bij patiënten met CAD, ook gecorrigeerd voor verschillen 
in opleidingsniveau. Een slechte ervaren gezondeheid medieert de 
hogere sterfte onder Roma CAD patiënten echter niet. Wel hebben Roma 
patiënten met een slechte ervaren gezondheid een belangrijk verhoogd 
risico op overlijden na CAG.
Hoofdstuk 7 gaat in op de veranderingen in de klinische toestand, 
gezondheidsgedrag en ervaren gezondheid na CAG bij Roma en niet-Roma 
CAD patiënten. We vonden geen significante verschillen in verbetering 
na CAG van klinische status, gezondheidsgedrag- en ervaren gezondheid 
tussen Roma en niet-Roma met uitzondering van triglyceridenspiegel 
en de diastolische bloeddruk. De hogere sterfte na CAG bij Roma CAD 
patiënten is dus grotendeels niet te wijten aan een kleinere verbetering 
van hun klinische status, gezondheidsgedrag en ervaren gezondheid na 
CAG. Hun prognose kan met name worden verbeterd door het versnellen 
van hun toegang tot gezondheidszorg, wat betreft CAG.
Tenslotte worden in hoofdstuk 8 alle bevindingen samengevat en 
besproken in het kader van de bestaande kennis en het eerder geformuleerde 
theoretisch model. Implicaties voor de praktijk en toekomstig onderzoek 
worden vervolgens beschreven. We vonden dat Roma etniciteit bij CAD 
samenhangt met slechtere uitkomsten. Roma patiënten met CAD die 
gebruik maken van de gespecialiseerde cardiologische zorg hebben een 
beduidend slechtere gezondheidstoestand dan niet-Roma patiënten. 
De lange-termijn sterfte bij Roma-patiënten na CAG is ongeveer twee 
keer zo hoog als bij niet-Roma patiënten en we vonden dat dit niet 
te wijten was aan leeftijd, geslacht, opleidingsniveau of behandeling 
na CAD. Het ontbreken van etnische verschillen in verbetering van de 
gezondheidstoestand en ervaren gezondheid bij Roma CAD patiënten na 
CAG in vergelijking met niet-Roma suggereert dat de deze verschillen in 
prognose geheel ontstaan in het traject voordat Roma de gespecialiseerde 
zorg binnenkomen. Deze feiten moeten artsen, huisartsen en cardiologen 
	 samenvatting
ervan doordringen dat zij Roma patiënten eerder moeten verwijzen voor 
diagnostiek en adequate behandeling van CAD dan nu het geval is. 
Ervaren gezondheid kan worden gebruikt als een eenvoudige voorspeller 
van sterfte bij Roma CAD patiënten ten tijde van de CAG. De oorzaken 
voor de vertraging tot de toegang tot de gezondheidszorg bij Roma 
patiënten behoeven nader onderzoek. We hopen dat dit proefschrift zal 




Cieľom tejto práce bolo preskúmať vzťah medzi rómskou etnicitou a prog-
nózou koronárnej choroby srdca (KCHS) u pacientov podstupujúcich 
selektívnu koronarografiu (SKG). V prvom rade sa táto práca zamerala 
na vzťah medzi rómskou etnicitou, medicínskymi rizikovými faktormi a 
závažnosťou KCHS na začiatku kardiologickej starostlivosti. Ďalej hod-
notila etnické rozdiely v mortalite po liečbe a zmeny klinického stavu, 
zdravotného správania a sebaposudzovaného zdravia (SPZ) počas sle-
dovaného obdobia. Okrem toho mala táto práca za cieľ poskytnúť vys-
vetlenie etnických rozdielov v celkovej mortalite u pacientov po SKG a 
hľadať vplyv rómskej ethnicity na mortalitu a SPZ.
V prvej úvodnej kapitole je popísaná definícia a epidemiológia 
KCHS, jej úmrtnosť a medicínske rizikové faktory ako aj iné faktory, ktoré 
k nej prispievajú. V ďalšom sa diskutuje rómska etnicita v kontexte KCHS, 
zvlášť rozdiely v rizikových faktoroch medzi rómami a nerómami. Potom 
sú formulované výskumné otázky, ktoré sú prepojené do modelu tejto 
práce. Kapitola sa končí osnovou práce.
Druhá kapitola poskytuje informácie o dizajne práce. Opisuje zber 
dát, súbor pacientov a merania použité v práci. Ďalej v krátkosti popisuje 
použité štatistické analýzy.
Tretia kapitola skúma rozdiely medzi medicínskymi rizikovými fak-
tormi a závažnosťou KCHS u rómskych a nerómskych pacientov. Róm-
ski pacienti mali významne viac rizikových faktorov ako aj závažnejšie 
formy KCHS pri vstupe do kardiologickej starostlivosti než nerómovia. 
Boli menej často liečení statínmi a betablokátormi, častejšie ponechaní na 
konzervatívnej liečbe a chirurgicky revaskularizovaní, a to aj po kontrole 
na rozdiely v stupni vzdelania, pohlavie a vek. Tým pádom majú rómski 
pacienti s KCHS horší rizikový profil pri vstupe do starostlivosti a javia 
sa ako nedostatočne liečení v období pred vstupom v porovnaní s neróm-
skymi pacientami s KCHS.
V štvrtej kapitole bola hodnotená mortalita u rómskych a neróm-
skych pacientov po SKG. Sedemročná celková mortalita po SKG bola sig-
nifikantne vyššia u rómov než u nerómov a tieto rozdiely len čiastočne 
poklesli po kontrole na rozdiely v stupni vzdelania, pohlavie a vek. Vyššiu 
mortalitu u rómov po SKG možno len čiastočne vysvetliť nižším socioeko-
nomickým stavom tejto menšiny.
Piata kapitola stanovuje rozdiely v osemročnej mortalite po SKG 
medzi rómami a nerómami. Táto mortalita bola významne vyššia u ró-
mov než u nerómov po kontrole na rozdiely v stupni vzdelania, pohlavie, 
vek, závažnosť KCHS a spôsob liečby. Z medicínskych rizikových faktorov 
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asociovaných so zvýšeným rizikom smrti u rómskych pacientov mali 
najvyššie riziká funkčné triedy NYHA III. a IV. Vzostup rómskej mortality 
po SKG sa dá čiastočne vysvetliť ich nižším vzdelaním a horším klinickým 
stavom.
V šiestej kapitole bol skúmaný vzťah medzi sebaposudzovaným 
zdravím (SPZ), rómskou etnicitou a mortalitou po SKG u pacientov 
s KCHS. Zistili sme, že rómska etnicita ako aj zlé SPZ boli prediktormi 
zvýšenej deväťročnej celkovej mortality u pacientov s KCHS aj po kon-
trole na rozdiely v stupni vzdelania. Zlé SPZ nebolo mediátorom vyššej 
mortality u rómskych pacientov s KCHS. Rómski pacienti so zlým SPZ 
majú preto významne vyššie riziko úmrtia po SKG.
Siedma kapitola sa zaoberá zmenami v klinickom stave, zdravotnom 
správaní a SPZ po SKG u rómskych a nerómskych pacientov s KCHS. 
Nezistili sme žiadne signifikantné rozdiely v zlepšení klinického stavu, 
zdravotného správania a SPZ po SKG medzi rómami a nerómami okrem 
triglyceridov a diastolického krvného tlaku. Vyššia mortalita po SKG 
u rómskych pacientov s KCHS nie je teda hlavne v dôsledku horšieho 
zlepšenia ich klinického stavu, zdravotného správania a SPZ po SKG. 
Ich prognózu možno zvlášť vylepšiť zlepšením ich prístupu k zdravotnej 
starostlivosti, čo sa týka SKG.
V ôsmej kapitole sú nakoniec zhrnuté všetky zistenia, ktoré sú 
diskutované v kontexte existujúcich poznatkov a teoretického modelu. 
Následne sú naznačené dôsledky pre prax a budúci výskum. Zistili sme, 
že rómska etnicita pri KCHS je spojená s horšou prognózou. Rómski 
pacienti s KCHS, ktorí vstupujú do špecializovanej kardiologickej sta-
rostlivosti, majú významne horší zdravotný stav ako ich nerómske nápro-
tivky. Dlhodobá mortalita u rómskych pacientov po SKG je približne 
dvojnásobne vyššia ako mortalita nerómskych pacientov. Zistili sme, že 
to nie je kvôli veku, pohlaviu, vzdelaniu alebo liečbe po SKG. Chýbanie 
etnických rozdielov v zlepšení zdravotného stavu a SPZ u rómov s KCHS 
po SKG v porovnaní s nerómami naznačuje, že pôvod týchto rozdielov 
leží úplne v trajektórii pred vstupom do procesu zdravotnej starostlivosti. 
Tieto poznatky by mali podnecovať internistov, všeobecných lekárov a 
kardiológov k tomu, aby posielali rómskych pacientov na diagnostiku a 
adekvátnu liečbu KCHS skôr, než sa to deje dnes. SPZ možno používať 
ako jednoduchý prediktor mortality u rómskych pacientov s KCHS v čase 
SKG. Oneskorenie v dostupnosti procesu zdravotnej starostlivosti u róm-
skych pacientov je potrebné preskúmať v budúcom výskume. Dúfame, 
že táto práca prispeje k lepšiemu porozumeniu relatívne zlej prognózy 
rómskych pacientov s KCHS.
	 zhrnutie
Acknowledgment
First of all, I would like to address my thanks to all the patients who were 
willing to participate in this study.
From the University Medical Centre Groningen, I would like to express my 
thanks to all members of the Department of Community & Occupational 
Health, especially to my promoter and supervisors:
- Prof. Sijmen A. Reijneveld, my promoter, for his constant support and 
many stimulating and important comments that have helped me to 
finish this thesis.
- Dr. Jitse P. van Dijk, my co-supervisor, also for his continuous support 
over the years of my PhD Study, and for not losing faith in me despite 
all the circumstances. Without his commitment in the research pro-
jects in Košice, the successful defence of the theses of my predecessors 
as well as mine would be unthinkable.
- I would like to thank the members of the Assessment Committee, 
Prof. E.Buskens, Prof. J.A.M. van Oers and Prof. G.Valocik, for assess-
ing this thesis.
- My thank goes to Roy E. Stewart, for his help with statistical analysis.
Next, I would like to express my gratitude to several people in Slovakia:
- Dr. Jaroslav Rosenberger, my supervisor, for his willingness to help me 
with statistical tips and tricks when writing the articles.
- Dr. Martin Studenčan, for inviting me to take part in this project
- Dr. Iveta Rajničová Nagyová, for help with the first article
- my colleagues Helena Vargová and Daniela Ondušová, who shared 
this project with me and took part a great deal in the data collection
- psychologists Zuzana Škodová and Barbora Šilárová, for their coope-
ration on this project
- Diana Matláková and Cecília Bukátová, who were research assistants 
and did data collection, nurses from the Cardiology Department for 
their cooperation during data collection
- I would like to thank to all my colleagues from KISH: Martina Súke-
niková, Ivana Borysová, Nicol Hendrichovská, Mária Majerníková, 
Martina Behánová, Jana Holubčíková, Martina Chýlová and many 
others.
- I would like to thank David McLean for proofreading my articles and 
this thesis.
104 105
Finally, I would like to thank my beloved husband Milan, my dearest 
children Aninka and Maťko and my parents for their support over the 




Adriana Sudzinová, born Čverčková, was born on September 2nd, 1975, in 
Košice, Slovakia. After finishing her medical studies at the Medical Faculty 
of P.J. Šafárik University in Košice in 1999, she started working as a doctor 
at the Cardiology Department of the University Hospital in Košice. In 
2002 she passed her first specialization examination in Internal Medicine. 
Since 2004 she has continued to work at the Arrhythmology Department 
of the East Slovakian Institute for Cardiac and Vascular Diseases. In 2007 
she passed the specialization examination in Cardiology at the National 
Institute for Cardiac and Vascular Diseases in Bratislava. In 2004 she 
began her PhD Study at the University of Groningen, the Netherlands, in 
the framework of the Košice Institute for Society and Health as an external 
student. After a break, she continued in 2010 to work on the project “Social 
class and its impact on a patient’s functional status and recovery process 
after cardiological or cardiosurgical intervention”, which was conducted 
in the East Slovakian Institute for Cardiac and Vascular Diseases based 
on the cooperation  between the University of Groningen, Pavol Jozef 
Šafárik University in Košice and the East Slovakian Institute of Cardiac 
and Vascular diseases in Košice.
106 107	 graduate	sChool	kosiCe	institute	for	soCiety	and	health	(kish)		
	 and	previous	dissertations
Graduate School Kosice Institute for 
Society and Health (KISH) and previous 
dissertations
The Graduate School Kosice Institute for Society and Health (KISH) was 
established in 2004. The Graduate School KISH is hosted by the Medical 
Faculty of Pavol Jozef Safarik University in Kosice (Slovakia). KISH 
researchers originate from the Medical Faculty, the University Hospital 
and other hospitals, and the Faculty of Arts. Its research concentrates on 
public health, health psychology, epidemiology and medical sociology. 
The interdisciplinary research programs focus on Youth and Health and 
on Chronic Disease. 
The Graduate School KISH is collaborating closely with the Division of 
Community and Occupational Medicine, University Medical Center 
Groningen, University of Groningen, The Netherlands. 
Previous dissertations from the Graduate School KISH
Skorvanek M (2014) Apathy, fatigue and quality of life in patients with 
Parkinson’s disease
 Supervisors:   Prof. Dr. JW Groothoff, Prof. Dr. Z Gdovinova
 Co-supervisors:  Assoc. Prof. Dr. JP van Dijk, Dr. J Rosenberger 
 http://irs.ub.rug.nl/ppn/383987016 
Kolvek G (2014) Etiology and prognosis of chronic kidney disease in children: 
Roma ethnicity and other risk factors
 Supervisors:   Prof. Dr. SA Reijneveld, Prof. Dr. L Podracka
 Co-supervisors:  Assoc. Prof. Dr. JP van Dijk, Dr. J Rosenberger 
 http://irs.ub.rug.nl/ppn/384001246
Mikula P (2014) Health related quality of life in people with multiple sclerosis : 
the role of coping, social participation and self-esteem
 Supervisors:   Prof. Dr. JW Groothoff, Prof. Dr. Z Gdovinova
 Co-supervisors:  Assoc. Prof. Dr. JP van Dijk, Dr. I Nagyova 
 http://irs.ub.rug.nl/ppn/386019940
108 109
Prihodova L (2014) Psychosocial and medical determinants of long-term patient 
outcomes. A specific focus on patients after kidney transplantation and 
with haemophilia
 Supervisor:   Prof. Dr. JW Groothoff
 Co-supervisors:  Assoc. Prof. Dr. JP van Dijk, Dr. I Nagyova, 
    Dr. J Rosenberger 
 http://irs.ub.rug.nl/ppn/381201090 
Behanova M (2014) Area- and individual-level socioeconomic differences in 
health and health-risk behaviours
 Supervisor:   Prof. Dr. SA Reijneveld
 Co-supervisors:  Assoc. Prof. Dr. JP van Dijk, Dr. I Nagyova, 
    Dr. Z Katreniakova
 http://irs.ub.rug.nl/ppn/375806504
Silarova B (2014) Unraveling the role of sense of coherence in coronary heart 
disease patients
 Supervisor:   Prof. Dr. SA Reijneveld
 Co-Supervisors: Assoc. Prof. Dr. JP van Dijk, Dr. I Nagyova
 http://irs.ub.rug.nl/ppn/371319919 
Pitel L (2013) Sociocultural determinants, gender and health-related behaviour 
in adolescence
 Supervisor:   Prof. Dr. SA Reijneveld
 Co-Supervisors: Assoc. Prof. Dr. JP van Dijk, Assoc. Prof. A 
Madarasova Geckova
 http://irs.ub.rug.nl/ppn/369599624
Majernikova M (2013) Self-rated health and mortality after kidney 
transplantation
 Supervisor:   Prof. Dr. JW Groothoff
 Co-Supervisors: Assoc. Prof. Dr. JP van Dijk, Dr. J Rosenberger,
    Dr. R Roland
 http://irs.ub.rug.nl/ppn/369598342
Bobakova D (2013) Youth subcultures and problem behaviours in Slovakia: Hip-
Hop, Techno-scene, Metal, Punk, Skinheads, and Roma
 Supervisor:   Prof. Dr. SA Reijneveld
 Co-Supervisors: Assoc. Prof. Dr. JP van Dijk,




Rosicova K (2013) Regional mortality in Slovakia: socioeconomic indicators and 
ethnicity
 Supervisor: Prof. Dr. JW Groothoff
 Co-Supervisors: Assoc. Prof. Dr. JP van Dijk, Assoc. Prof. A 
Madarasova Geckova
 http://irs.ub.rug.nl/ppn/357966791 
Benka J (2012) Living with Rheumatoid Arthritis: do personal and social 
resources make a difference?
 Supervisor:   Prof. Dr. JW Groothoff, Prof. Dr. JJL van der Klink
 Co-Supervisors: Assoc. Prof. Dr. JP van Dijk, Dr. I Nagyova
 http://irs.ub.rug.nl/ppn/354811118 
Kalina O (2012) Sexual risky behaviour among Slovak adolescents and young 
adults: social an psychological factors
 Supervisor:   Prof. Dr. SA Reijneveld 
 Co-Supervisors: Assoc. Prof. Dr. JP van Dijk,
    Assoc. Prof. A Madarasova Geckova
 http://irs.ub.rug.nl/ppn/353218561 
Salonna F (2012) Health inequalities among Slovak adolescents over time
 Supervisors:   Prof. Dr. SA Reijneveld, Prof. Dr. JW Groothoff
 Co-Supervisors: Assoc. Prof. Dr. JP van Dijk,
    Assoc. Prof. A Madarasova Geckova
 http://irs.ub.rug.nl/ppn/345879597 
Kolarcik P (2012) Self-reported health and health risky behaviour of Roma 
adolescents in Slovakia. A comparison with the non-Roma
 Supervisor: Prof. Dr. SA Reijneveld 
 Co-Supervisors: Assoc. Prof. Dr. JP van Dijk,
    Assoc. Prof. A Madarasova Geckova
 http://irs.ub.rug.nl/ppn/345878396
Tomcikova Z (2011) Parental divorce and adolescent excessive drinking: Role of 
parent – adolescent relationship and other social and psychosocial factors.
 Supervisor:   Prof. Dr. SA Reijneveld 
 Co-Supervisors: Assoc. Prof. Dr. JP van Dijk,
    Assoc. Prof. A Madarasova Geckova
 http://irs.ub.rug.nl/ppn/332352617
110 111
Veselska Z (2010) Perception of self and health-related behavior in adolescence
 Supervisor:   Prof. Dr. SA Reijneveld 
 Co-Supervisors: Assoc. Prof. Dr. JP van Dijk,
    Assoc. Prof. A Madarasova Geckova
 http://irs.ub.rug.nl/ppn/330592696
Dubayova T (2010) Parkinson’s disease – psychological determinants of quality of life
 Supervisor:   Prof. Dr. JW Groothoff
 Co-Supervisors: Assoc. Prof. Dr. JP van Dijk, Dr. I Nagyova,
    Assoc. Prof. Dr. Z Gdovinova, Dr. BJ Middel
 http://irs.ub.rug.nl/ppn/330630423 
Sarkova M (2010) Psychological well-being and self-esteem in Slovak adolescents
 Supervisor:   prof dr WJA van den Heuvel
 Co-Supervisors: Assoc. Prof. Dr. JP van Dijk, Dr. Z. Katreniakova,
    Assoc. Prof. A Madarasova Geckova
 http://irs.ub.rug.nl/ppn/330592173
Krokavcova M (2009) Perceived Health Status in Multiple Sclerosis Patients 
 Supervisor:   Prof. Dr. JW Groothoff
 Co-Supervisors: Assoc. Prof. Dr. JP van Dijk, Dr. I Nagyova,
    Assoc. Prof. Dr. Z Gdovinova, Dr. BJ Middel
 http://irs.ub.rug.nl/ppn/318259753
Havlikova E (2008) Fatigue, mood disorders and sleep problems in patients with 
Parkinson’s disease
 Supervisor:   Prof. Dr. JW Groothoff
 Co-Supervisors: Assoc. Prof. Dr. JP van Dijk, Dr. J Rosenberger,
    Assoc. Prof. Dr. Z Gdovinova, Dr. BJ Middel
 http://irs.ub.rug.nl/ppn/315252448
Zuzana Skodova (2008) Coronary heart disease from a psychosocial perspective: 
socioeconomic and ethnic inequalities among Slovak patients
 Supervisor:   Prof. Dr. SA Reijneveld 
 Co-Supervisors: Assoc. Prof. Dr. JP van Dijk, Dr. I Nagyova, 




Rosenberger J (2006) Perceived health status after kidney transplantation
 Supervisors:   Prof. Dr. JW Groothoff, 
    Prof. Dr. WJA van den Heuvel
 Co-Supervisors: Dr. JP van Dijk, Dr. R Roland
 http://irs.ub.rug.nl/ppn/297874527 
Sleskova M (2006) Unemployment and the health of Slovak adolescents
 Supervisors:   Prof. Dr. SA Reijneveld, Prof. Dr. JW Groothoff
 Co- Supervisors: Dr. JP van Dijk, Dr. A Madarasova Geckova
 http://irs.ub.rug.nl/ppn/297872109 
Nagyova I (2005) Self-rated health and quality of life in Slovak rheumatoid 
arthritis patients
 Supervisors:   Prof. Dr. WJA van den Heuvel
 Co-Supervisor: Dr. JP van Dijk
 http://irs.ub.rug.nl/ppn/274118556 
Geckova A (2002) Inequality in health among Slovak adolescents.
 Supervisors:   Prof. Dr. D Post, Prof. Dr. JW Groothoff




Groningen Graduate School of Medical 
Sciences – Research Institute SHARE 
and previous dissertations 
This thesis is published within the Research Institute SHARE (Science 
in Healthy Ageing and healthcaRE) of the University Medical Center 
Groningen / University of Groningen.
Further information regarding the institute and its research can be 
obtained from our internetsite: http://www.share.umcg.nl/.
More recent theses can be found in the list below.
((co-) supervisors are between brackets)
2015
Meijer MF
Innovations in revision total knee arthroplasty
(prof SK Bulstra, dr M Stevens, dr IHF Reininga)
Pitman JP
The influence and impact of the U.S. President’s Emergencey Plan for 
AIDS Relief (PEPFAR) on blood transfusion in Africa; case studies from 
Namibië
Prof MJ Postma, prof TS van der Werf) 
Scheppingen C van
Distress and unmet needs in cancer patients; challenges in intervention 
research
(prof R Sanderman, dr G Pool, dr MJ Schroevers)
Bouwman II
Lower urinary tract symptoms in older men: does it predict the future?
(prof K van der Meer, prof JM Nijman, dr WK van der Heide)
Geurts, MME
Integrated pharmaceutical care; cooperation between pharmacist, general 
practitioner, and patient and the development of a pharmaceutical care 
plan
(prof JJ de Gier, prof JRBJ Brouwers, prof PA de Graeff)
114 115
Sun J
Developing comprehensive and integrated health system reform policies 
to improve use of medicines in China
(prof HV Hogerziel, prof SA Reijneveld)
Wyk, L van
Management of term growth restriction; neonatal and long term outcomes
(prof SA Scherjon, prof JMM van Lith, dr KE Boers, dr S le Cessie)
Vos FI
Ultrasonography of the fetal nose, maxilla, mandible and forehead as 
markers for aneuploidy
(prof CM Bilardo, prof KO Kagan, dr EAP de Jong-Pleij)
Twillert S van
Linking scientific and clinical knowledge practices; innovation for 
prosthetic rehabilitation
(prof K Postema, prof JHB Geertzen, dr A Lettinga)
Loo HM van
Data-driven subtypes of major depressive disorder
(prof RA Schoevers, prof P de Jonge, prof JW Romeijn)
Raat AN
Peer influence in clinical worokplace learning; a study of medical 
students’use of social comparison in clinical practice
(prof J Cohen-Schotanus, prof JBM Kuks)
Standaert BACGM
Exploring new ways of measuring the economic value of vaccination with 
an application to the prevention of rotavirus disease
(prof MJ Postma, dr O Ethgen)
Kotsopoulos N
Novel economic perspectives on prevention and treatment: case studies 
for paediatric, adolescent and adult infectious diseases
(prof MJ Postma, dr M Connolly)
Feijen-de Jong, EI
On the use and determinants of prenatal healthcare services




The value of a family-centered approach in preventive child healthcare
(prof SA Reijneveld, dr A de Winter)
Dul EC
Chromosomal abnormalities in infertile men and preimplantation 
embryos
(prof JA Land, prof CMA van Ravenswaaij-Arts)
Heeg BMS
Modelling chronic diseases for reimbursement purposes
(prof MJ Postma, prof E Buskens, prof BA van Hout)
Vries, ST de
Patient perspectives in the benefit-risk evaluation of drugs
(prof P Denig, prof FM Haaijer-Ruskamp, prof D de Zeeuw)
Zhu L
Patterns of adaptation to cancer during psychological care
(prof AV Ranchor, prof R Sanderman, dr MJ Schroevers)
Peters LL
Towards tailored elderly care with self-assessment measures of frailty and 
case complexity
(prof E Buskens, prof JPJ Slaets, dr H Boter)
Vart P
Prevention of chronic kidney disease and its concequences; the role of 
socioeconomic status
(prof SA Reijneveld, prof U Bültmann, prof RT Gansevoort)
Mutsaerts M
Lifestyle and reproduction
(prof JA Land, prof BW Mol, dr A Hoek, dr H Groen)
Sulkers E
Psychological adaptation to childhood cancer
(prof R Sanderman, prof PF Roodbol, prof ESJM de Bont, dr J Fleer, dr WJE 
Tissing)
Febrianna SA
Skin problems related to Indonesian leather & shoe production and the 
use of footwear in Indonesia




Asymptomatic bacteruiria and urinary tract infections in women: focus 
on diabetes mellitus and pregnancy
(prof RP Stolk, prof JJHM Erwich, dr SE Geerlings)
Skorvanek, M
Fatigue, apathy and quality of life in patients with Parkinson’s disease
(prof JW Groothoff, prof Z Gdovinova, dr JP van Dijk, dr J Rosenberger)
Kolvek G
Etiology and prognosis of chronic kidney disease in children: Roma 
ethnicity and other risk factors
(prof SAReiijneveld, prof L Podracka, dr JP van Dijk, dr J Rosenberger)
Mikula P
Health related quality of life in people with multiple sclerosis; the role of 
coping, social participation and self-esteem
(prof JW Groothoff, prof Z Gdovinova, dr JP van Dijk, dr I Nagyova)
Amalia R
Improving a school-based dental programme through a sociodental risk 
group approach
(prof RMH Schaub, prof JW Groothoff, prof N Widyanti)
Christoffers WA
Hand eczema; interventions and contact allergies
(prof PJ Coenraads, dr MLA Schuttelaar)
Troquete NAC
START-ing risk assessment and shared care planning in out-patient 
forensic psychiatry; results from a cluster randomized controlled trial
(prof D Wiersma, prof RA Schoevers, dr RHS van den Brink)
For more 2014 and earlier theses visit our website
	 groningen	graduate	sChool	of	mediCal	sCienCes	–	
	 researCh	institute	share	and	previous	dissertations
ISBN 978-90-367-8365-1
